locus_id	good_cs	chrom	pval	mlogp	lead_beta	lead_enrichment	lead_af_alt	lead_most_severe_gene	functional_variants_strict	credible_set_variants	cs_log_bayes_factor	all_traits_strict	all_traits_relaxed	ukbb_pval
chr20_59159857_G_A	true	20	2.25e-33	32.6	0.136	1.5912467824648469	0.168	ZNF831	NA	chr20_59126599_G_A|0.00225|0.883;chr20_59130459_T_C|0.00216|0.963;chr20_59130557_T_A|0.00214|0.963;chr20_59131351_C_T|0.00214|0.963;chr20_59131469_T_G|0.00214|0.963;chr20_59134110_A_G|0.00214|0.963;chr20_59134870_A_G|0.00213|0.963;chr20_59136043_C_G|0.00214|0.963;chr20_59136831_G_A|0.00215|0.963;chr20_59137229_T_A|0.00214|0.963;chr20_59138259_G_A|0.00214|0.964;chr20_59143635_T_C|0.00247|0.963;chr20_59147680_T_A|0.00225|0.964;chr20_59148075_C_T|0.00215|0.964;chr20_59150034_G_A|0.00223|0.965;chr20_59150608_G_A|0.00266|0.964;chr20_59150882_C_A|0.00266|0.964;chr20_59151068_A_C|0.00227|0.965;chr20_59151307_T_C|0.00229|0.965;chr20_59152327_T_C|0.00272|0.964;chr20_59153214_C_T|0.00235|0.965;chr20_59154160_C_T|0.0023|0.965;chr20_59154304_A_C|0.00229|0.966;chr20_59155193_A_G|0.00224|0.966;chr20_59155363_T_C|0.00222|0.966;chr20_59156215_C_A|0.00217|0.966;chr20_59156820_G_A|0.00216|0.966;chr20_59158279_A_G|0.00757|0.974;chr20_59159857_G_A|0.234|1;chr20_59160393_G_A|0.233|1;chr20_59160402_A_C|0.00572|0.911;chr20_59161276_GT_G|0.177|0.996;chr20_59164754_C_T|0.147|0.998;chr20_59164774_A_G|0.00502|0.984;chr20_59165293_A_G|0.00255|0.984;chr20_59165381_C_T|0.0734|0.997;chr20_59165550_G_A|0.00255|0.984;chr20_59185668_A_G|0.00273|0.898	31.9	Beta blocking agent use measurement|1;Diuretic use measurement|1;mean arterial pressure|0.984;alcohol drinking|0.984;diastolic blood pressure|0.984;alcohol consumption measurement|0.984;systolic blood pressure|0.964;cardiovascular disease|0.963;Calcium channel blocker use measurement|0.911	hypertension|0.935;Beta blocking agent use measurement|1;Diuretic use measurement|1;alcohol consumption measurement|0.984;mean arterial pressure|0.984;alcohol drinking|0.984;diastolic blood pressure|0.984;Agents acting on the renin-angiotensin system use measurement|0.984;systolic blood pressure|0.984;cardiovascular disease|0.963;smoking status measurement|0.935;Calcium channel blocker use measurement|0.911;coronary artery disease|0.888;body height|0.656;lymphocyte count|0.344;lymphocyte percentage of leukocytes|0.344;platelet component distribution width|0.336;hair color|0.135	NA
chr1_10736809_T_C	true	1	1.34e-32	31.9	0.102	1.2560522470588231	0.413	CASZ1	NA	chr1_10736809_T_C|0.993|1	22.8	hypertension|1;systolic blood pressure|1;diastolic blood pressure|1;pulse pressure measurement|1;mean arterial pressure|1;smoking status measurement|1;Calcium channel blocker use measurement|1;Agents acting on the renin-angiotensin system use measurement|1;Diuretic use measurement|1;low density lipoprotein cholesterol measurement|1;triglyceride measurement|1;atrial fibrillation|1;stroke|1;Ischemic stroke|1;cardiovascular disease|1	hypertension|1;triglyceride measurement|1;smoking status measurement|1;cardiovascular disease|1;Ischemic stroke|1;stroke|1;atrial fibrillation|1;systolic blood pressure|1;pulse pressure measurement|1;diastolic blood pressure|1;mean arterial pressure|1;low density lipoprotein cholesterol measurement|1;Diuretic use measurement|1;Agents acting on the renin-angiotensin system use measurement|1;Calcium channel blocker use measurement|1;treatment-resistant hypertension|0.909;apolipoprotein B measurement|0.909;Beta blocking agent use measurement|0.909;Atrial Fibrillation|0.808;breast carcinoma|0.145;estrogen-receptor negative breast cancer|0.145;Breast cancer|0.145;asthma|0.116	NA
chr4_80261400_T_C	true	4	3.0799999999999997e-30	29.5	0.105	1.0169178616433905	0.313	NA	NA	chr4_80259918_A_T|0.18|0.995;chr4_80261400_T_C|0.557|1;chr4_80263187_A_T|0.263|0.998	22.9	hypertension|0.995;glomerular filtration rate|1;systolic blood pressure|1;alcohol drinking|1;diastolic blood pressure|1;chronic kidney disease|1;mean arterial pressure|1;pulse pressure measurement|1;hematocrit|1;erythrocyte count|1;potassium measurement|1;blood urea nitrogen measurement|1;red blood cell density measurement|1;coronary artery disease|0.995;uric acid measurement|0.995;urate measurement|0.995;creatinine measurement|0.995;Calcium channel blocker use measurement|0.995;Diuretic use measurement|0.995	hypertension|0.995;glomerular filtration rate|1;diastolic blood pressure|1;red blood cell density measurement|1;pulse pressure measurement|1;blood urea nitrogen measurement|1;systolic blood pressure|1;alcohol drinking|1;chronic kidney disease|1;mean arterial pressure|1;potassium measurement|1;erythrocyte count|1;hematocrit|1;coronary artery disease|0.995;Calcium channel blocker use measurement|0.995;uric acid measurement|0.995;creatinine measurement|0.995;urate measurement|0.995;Diuretic use measurement|0.995;alcohol consumption measurement|0.84;smoking status measurement|0.84;apolipoprotein B measurement|0.84;atrial fibrillation|0.84;low density lipoprotein cholesterol measurement|0.84;Atrial Fibrillation|0.84;hemoglobin measurement|0.84;HMG CoA reductase inhibitor use measurement|0.84;Beta blocking agent use measurement|0.84;Agents acting on the renin-angiotensin system use measurement|0.84;cardiovascular disease|0.84;PR interval|0.645;hair colour measurement|0.351;hair color|0.351;synophrys measurement|0.343;balding measurement|0.334;Alopecia|0.311;androgenetic alopecia|0.311	NA
chr1_112501706_G_T	true	1	1.26e-29	28.9	0.127	2.5059883980582525	0.17	WNT2B	NA	chr1_112496139_G_C|0.0395|0.867;chr1_112500200_T_C|0.187|0.994;chr1_112500801_A_G|0.186|0.994;chr1_112501706_G_T|0.391|1;chr1_112504257_C_A|0.111|0.993;chr1_112510401_A_C|0.0505|0.959	17.5	hypertension|1;systolic blood pressure|1;mean arterial pressure|1;diastolic blood pressure|1;Beta blocking agent use measurement|1;potassium measurement|0.994;stroke|0.994;pulse pressure measurement|0.993;Calcium channel blocker use measurement|0.993;cardiovascular disease|0.993;Agents acting on the renin-angiotensin system use measurement|0.993	hypertension|1;systolic blood pressure|1;mean arterial pressure|1;diastolic blood pressure|1;Beta blocking agent use measurement|1;stroke|0.994;potassium measurement|0.994;Calcium channel blocker use measurement|0.993;pulse pressure measurement|0.993;cardiovascular disease|0.993;Agents acting on the renin-angiotensin system use measurement|0.993;Diuretic use measurement|0.493;physical activity measurement|0.33;BMI-adjusted waist circumference|0.33;intraocular pressure measurement|0.244;body height|0.189;total cholesterol measurement|0.188;visual cortical surface area measurement|0.139;mean platelet volume|0.112	NA
chr7_150993088_C_T	true	7	2.5299999999999997e-28	27.6	0.182	0.9164068524515392	0.0701	NOS3	NA	chr7_150993088_C_T|1|1	19.7	systolic blood pressure|1;coronary artery disease|1;Eczema|1;cardiovascular disease|1;body height|1;Diuretic use measurement|1;Beta blocking agent use measurement|1;HMG CoA reductase inhibitor use measurement|1;Agents acting on the renin-angiotensin system use measurement|1;Calcium channel blocker use measurement|1;mean platelet volume|1;parental genotype effect measurement|1;birth weight|1;diastolic blood pressure|1;alcohol drinking|1;smoking status measurement|1;allergic rhinitis|1	coronary artery disease|1;birth weight|1;systolic blood pressure|1;diastolic blood pressure|1;Eczema|1;allergic rhinitis|1;smoking status measurement|1;parental genotype effect measurement|1;alcohol drinking|1;mean platelet volume|1;Calcium channel blocker use measurement|1;Agents acting on the renin-angiotensin system use measurement|1;HMG CoA reductase inhibitor use measurement|1;Beta blocking agent use measurement|1;Diuretic use measurement|1;body height|1;cardiovascular disease|1;appendicular lean mass|0.153	NA
chr1_11827628_G_GTTTCACCACTTTGGCAAGGCTGGTCTTGAA	true	1	2.3199999999999997e-26	25.6	-0.128	0.9516155554156172	0.14400000000000002	CLCN6	NA	chr1_11802721_A_G|0.0127|0.993;chr1_11805747_A_G|0.0503|0.992;chr1_11813359_A_C|0.0377|0.997;chr1_11813730_T_C|0.0377|0.997;chr1_11816243_T_G|0.0429|0.997;chr1_11819642_A_G|0.04|0.997;chr1_11820674_G_T|0.04|0.997;chr1_11820680_T_C|0.04|0.997;chr1_11820681_G_T|0.04|0.997;chr1_11820684_A_T|0.04|0.997;chr1_11820691_T_C|0.04|0.997;chr1_11820698_C_T|0.0362|0.997;chr1_11820703_C_G|0.04|0.997;chr1_11820711_A_G|0.04|0.997;chr1_11821384_C_G|0.0164|0.995;chr1_11821890_C_CAG|0.04|0.997;chr1_11823674_C_T|0.0471|0.997;chr1_11825590_A_G|0.0349|0.997;chr1_11826326_C_CTG|0.0376|0.997;chr1_11827246_A_G|0.037|0.997;chr1_11827325_A_G|0.04|0.997;chr1_11827628_G_GTTTCACCACTTTGGCAAGGCTGGTCTTGAA|0.0568|1;chr1_11832558_G_C|0.0377|0.997;chr1_11835618_A_G|0.033|0.997;chr1_11835738_G_A|0.0372|0.997	18.2	hypertension|0.993;diastolic blood pressure|0.997;mean corpuscular hemoglobin concentration|0.997;mean arterial pressure|0.997;alcohol drinking|0.997;Agents acting on the renin-angiotensin system use measurement|0.997;Beta blocking agent use measurement|0.997;cardiovascular disease|0.997;QRS amplitude|0.997;QRS complex|0.997;systolic blood pressure|0.997;alcohol consumption measurement|0.997;pulse pressure measurement|0.993;smoking status measurement|0.993;birth weight|0.993;parental genotype effect measurement|0.993;mean platelet volume|0.993;red blood cell folate measurement|0.992	hypertension|0.993;systolic blood pressure|0.997;mean arterial pressure|0.997;alcohol drinking|0.997;diastolic blood pressure|0.997;Beta blocking agent use measurement|0.997;alcohol consumption measurement|0.997;mean corpuscular hemoglobin concentration|0.997;Agents acting on the renin-angiotensin system use measurement|0.997;cardiovascular disease|0.997;QRS amplitude|0.997;QRS complex|0.997;mean platelet volume|0.993;pulse pressure measurement|0.993;smoking status measurement|0.993;parental genotype effect measurement|0.993;birth weight|0.993;red blood cell folate measurement|0.992;mean corpuscular hemoglobin|0.978;mean corpuscular volume|0.978;red blood cell density measurement|0.977;erythrocyte count|0.976;triglyceride measurement|0.72;NT-proBNP measurement|0.364;BNP measurement|0.266;cardiovascular disease biomarker measurement|0.264;blood protein measurement|0.264;natriuretic peptides B measurement|0.247;eosinophil count|0.139;body mass index|0.125;Moyamoya disease|0.102;red blood cell distribution width|0.102	NA
chr15_90886057_A_C	true	15	4.0999999999999993e-26	25.4	0.10099999999999999	0.7175127907639681	0.267	FES	NA	chr15_90875067_T_A|0.0141|0.952;chr15_90882002_C_T|0.0183|0.959;chr15_90884382_G_A|0.0607|0.98;chr15_90884642_G_C|0.05|0.981;chr15_90885291_CT_C|0.0798|0.975;chr15_90885725_C_T|0.0694|0.981;chr15_90885946_G_T|0.194|0.999;chr15_90885966_CCA_C|0.194|0.999;chr15_90886057_A_C|0.281|1	20.5	hypertension|0.999;hair colour measurement|1;coronary artery disease|1;birth weight|1;alcohol drinking|0.999;systolic blood pressure|0.999;Calcium channel blocker use measurement|0.981;cardiovascular disease|0.981;Agents acting on the renin-angiotensin system use measurement|0.981;alcohol consumption measurement|0.981;mean arterial pressure|0.981;diastolic blood pressure|0.981;pulse pressure measurement|0.981;trauma exposure measurement|0.959;schizophrenia|0.952;autism spectrum disorder|0.952;risk-taking behaviour|0.952	hypertension|0.999;hair colour measurement|1;coronary artery disease|1;birth weight|1;systolic blood pressure|0.999;alcohol drinking|0.999;mean arterial pressure|0.981;Calcium channel blocker use measurement|0.981;alcohol consumption measurement|0.981;Agents acting on the renin-angiotensin system use measurement|0.981;diastolic blood pressure|0.981;cardiovascular disease|0.981;pulse pressure measurement|0.981;trauma exposure measurement|0.959;risk-taking behaviour|0.952;autism spectrum disorder|0.952;schizophrenia|0.952;asthma|0.712;myeloid white cell count|0.549;Diuretic use measurement|0.549;neutrophil count|0.549;Beta blocking agent use measurement|0.536;parental genotype effect measurement|0.536;insomnia measurement|0.536;balding measurement|0.536;apolipoprotein A 1 measurement|0.535	NA
chr2_26688641_A_C	true	2	2.04e-25	24.7	-0.0886	0.8592855926583777	0.5489999999999999	KCNK3	NA	chr2_26688641_A_C|0.294|1;chr2_26688877_C_T|0.107|0.992;chr2_26691062_A_G|0.249|0.998;chr2_26691496_C_T|0.0268|0.973;chr2_26694101_C_T|0.156|0.996;chr2_26696221_C_T|0.0585|0.992;chr2_26700227_C_T|0.0291|0.99;chr2_26700700_T_C|0.0291|0.99	19.2	hypertension|0.973;potassium measurement|0.996;diastolic blood pressure|0.992;alcohol drinking|0.992;systolic blood pressure|0.992;mean arterial pressure|0.992;alcohol consumption measurement|0.99;pulse pressure measurement|0.99;Beta blocking agent use measurement|0.973;Mean Arterial Pressure|0.973;cardiovascular disease|0.973;Diuretic use measurement|0.973;smoking status measurement|0.973	hypertension|0.973;potassium measurement|0.996;systolic blood pressure|0.992;alcohol drinking|0.992;mean arterial pressure|0.992;diastolic blood pressure|0.992;alcohol consumption measurement|0.99;pulse pressure measurement|0.99;Diuretic use measurement|0.973;Beta blocking agent use measurement|0.973;cardiovascular disease|0.973;Mean Arterial Pressure|0.973;smoking status measurement|0.973;low density lipoprotein cholesterol measurement|0.972;Agents acting on the renin-angiotensin system use measurement|0.972;apolipoprotein B measurement|0.966;triglyceride measurement|0.832;body mass index|0.687;Calcium channel blocker use measurement|0.687;parental longevity|0.685;visceral adipose tissue measurement|0.139;grip strength measurement|0.138	NA
chr12_111427245_C_G	true	12	7.379999999999999e-23	22.1	-0.0844	1.1677669005292937	0.586	SH2B3	chr12_111446804_T_C|missense_variant|0.972	chr12_111427245_C_G|0.495|1;chr12_111446804_T_C|0.0939|0.972;chr12_111494996_C_T|0.179|0.996;chr12_111535554_A_G|0.14|0.996;chr12_111569952_C_T|0.0838|0.988	15.1	systolic blood pressure|1;alcohol drinking|1;alcohol consumption measurement|1;autoimmune disease|1;Diuretic use measurement|1;Beta blocking agent use measurement|1;Agents acting on the renin-angiotensin system use measurement|1;left ventricular diastolic function measurement|1;white matter microstructure measurement|1;fibrinogen measurement|1;mean arterial pressure|1;diastolic blood pressure|1;low density lipoprotein cholesterol measurement|1;high density lipoprotein cholesterol measurement|1;hypothyroidism|0.996;Colorectal cancer|0.996;waist-hip ratio|0.996;mean corpuscular hemoglobin|0.996;apolipoprotein B measurement|0.996;colorectal cancer|0.996;allergic rhinitis|0.996;systemic lupus erythematosus|0.996;gastroesophageal reflux disease|0.996;smoking behavior|0.996;colorectal adenoma|0.996;lymphocyte count|0.988;eosinophil percentage of leukocytes|0.988;eosinophil count|0.988;inflammatory bowel disease|0.988;Sarcoidosis|0.988;tonsillectomy risk measurement|0.988;type I diabetes mellitus|0.988;Eczema|0.988;asthma|0.988;total cholesterol measurement|0.988;Inflammatory Bowel Disease|0.988;thyroid peroxidase antibody measurement|0.988;basophil count|0.988;neutrophil percentage of granulocytes|0.988;cystatin C measurement|0.988;chronic kidney disease|0.988;celiac disease|0.988;immune system disease|0.988;urate measurement|0.988;eosinophil percentage of granulocytes|0.988;myocardial infarction|0.988;monocyte count|0.988;Type 1 Diabetes Mellitus|0.988	hypertension|0.915;mean arterial pressure|1;alcohol consumption measurement|1;autoimmune disease|1;Diuretic use measurement|1;Beta blocking agent use measurement|1;Agents acting on the renin-angiotensin system use measurement|1;left ventricular diastolic function measurement|1;white matter microstructure measurement|1;fibrinogen measurement|1;alcohol drinking|1;systolic blood pressure|1;low density lipoprotein cholesterol measurement|1;high density lipoprotein cholesterol measurement|1;diastolic blood pressure|1;hypothyroidism|0.996;Colorectal cancer|0.996;waist-hip ratio|0.996;mean corpuscular hemoglobin|0.996;apolipoprotein B measurement|0.996;colorectal cancer|0.996;systemic lupus erythematosus|0.996;allergic rhinitis|0.996;colorectal adenoma|0.996;gastroesophageal reflux disease|0.996;smoking behavior|0.996;neutrophil percentage of granulocytes|0.988;myocardial infarction|0.988;inflammatory bowel disease|0.988;monocyte count|0.988;thyroid peroxidase antibody measurement|0.988;basophil count|0.988;eosinophil count|0.988;asthma|0.988;eosinophil percentage of leukocytes|0.988;urate measurement|0.988;Eczema|0.988;eosinophil percentage of granulocytes|0.988;celiac disease|0.988;chronic kidney disease|0.988;cystatin C measurement|0.988;immune system disease|0.988;Sarcoidosis|0.988;tonsillectomy risk measurement|0.988;Inflammatory Bowel Disease|0.988;total cholesterol measurement|0.988;Type 1 Diabetes Mellitus|0.988;lymphocyte count|0.988;type I diabetes mellitus|0.988;parental longevity|0.915;eye measurement|0.915;left ventricular structural measurement|0.915;coronary artery disease|0.915;HbA1c measurement|0.915;heart failure|0.915;reaction time measurement|0.915;smoking status measurement|0.915;reticulocyte count|0.915;birth weight|0.915;childhood onset asthma|0.915;Vitiligo|0.915;smoking initiation|0.915;glomerular filtration rate|0.915;intraocular pressure measurement|0.9;rheumatoid arthritis|0.9;Seropositive Rheumatois Arthritis|0.9;psoriasis|0.885;primary biliary cirrhosis|0.885;Psoriaris|0.885;blood protein measurement|0.885;small vessel stroke|0.885;body mass index|0.878;large artery stroke|0.878;coronary heart disease|0.878;hemoglobin measurement|0.878;Tetralogy of Fallot|0.878;hematocrit|0.878;stroke|0.878;Ischemic stroke|0.862;peripheral arterial disease|0.763;systemic scleroderma|0.763;platelet count|0.763;myositis|0.763;Thyroid preparation use measurement|0.755;apolipoprotein A 1 measurement|0.755;immunoglobulin isotype switching measurement|0.61;breast carcinoma|0.389;small artery occlusion|0.227;platelet component distribution width|0.18;ankylosing spondylitis|0.154;adolescent idiopathic scoliosis|0.153;mean platelet volume|0.153;gastric carcinoma|0.149;gout|0.145;idiopathic osteonecrosis of the femoral head|0.145;uric acid measurement|0.145;hair color|0.114;drinking behavior|0.113;C-reactive protein measurement|0.112;metabolic syndrome|0.112;upper aerodigestive tract neoplasm|0.106	NA
chr9_133636606_C_T	true	9	1.4599999999999999e-21	20.8	-0.18600000000000003	17.68546843636364	0.0501	DBH	chr9_133636606_C_T|missense_variant|1	chr9_133636606_C_T|1|1	15.8	NA	NA	NA
chr19_11416089_T_G	true	19	7.85e-21	20.1	0.0803	NA	0.575	CCDC151	NA	chr19_11416089_T_G|1|1	9.66	NA	NA	NA
chr10_114021788_T_C	true	10	5.65e-19	18.2	0.079	0.9426381174934726	0.654	NA	NA	chr10_114021768_T_C|0.482|1;chr10_114021788_T_C|0.515|1	12	mean arterial pressure|1;smoking status measurement|1;diastolic blood pressure|1;systolic blood pressure|1	mean arterial pressure|1;smoking status measurement|1;diastolic blood pressure|1;systolic blood pressure|1;high density lipoprotein cholesterol measurement|0.362;Diuretic use measurement|0.362;birth weight|0.362;alcohol consumption measurement|0.356;alcohol drinking|0.356;infant head circumference|0.356;total cholesterol measurement|0.356;triglyceride measurement|0.356;low density lipoprotein cholesterol measurement|0.356;body height at birth|0.356;PR interval|0.309	NA
chr7_27203602_C_T	true	7	8.159999999999998e-19	18.1	0.129	0.9748374198856226	0.904	HOXA13	NA	chr7_27202740_A_C|0.107|0.997;chr7_27203602_C_T|0.108|1;chr7_27203619_G_A|0.107|1;chr7_27204343_A_G|0.106|0.997;chr7_27205482_G_T|0.107|0.997;chr7_27206274_T_C|0.107|0.997;chr7_27206374_GAGCA_G|0.108|1;chr7_27206378_A_ATT|0.108|1;chr7_27219669_A_G|0.0106|0.784;chr7_27237099_G_C|0.0128|0.766;chr7_27237293_AG_A|0.0128|0.766;chr7_27237296_G_C|0.0128|0.766;chr7_27237298_A_ACACT|0.0128|0.766;chr7_27238297_T_C|0.0127|0.766;chr7_27240226_C_CCAAA|0.014|0.766;chr7_27241538_T_C|0.0135|0.765	8.8	hypertension|0.997;smoking status measurement|1;systolic blood pressure|1;urinary albumin to creatinine ratio|1;albuminuria|1;diastolic blood pressure|1;pulse pressure measurement|1;Beta blocking agent use measurement|0.997;Agents acting on the renin-angiotensin system use measurement|0.997;cardiovascular disease|0.997;Calcium channel blocker use measurement|0.997;mean arterial pressure|0.997;potassium measurement|0.997	hypertension|0.997;systolic blood pressure|1;smoking status measurement|1;urinary albumin to creatinine ratio|1;albuminuria|1;diastolic blood pressure|1;pulse pressure measurement|1;Agents acting on the renin-angiotensin system use measurement|0.997;cardiovascular disease|0.997;Calcium channel blocker use measurement|0.997;mean arterial pressure|0.997;potassium measurement|0.997;Beta blocking agent use measurement|0.997;Diuretic use measurement|0.893;alcohol consumption measurement|0.573;alcohol drinking|0.573;ulcerative colitis|0.404;heel bone mineral density|0.115	NA
chr15_90897856_T_C	false	15	5.17e-18	17.3	0.0742	0.8549743088483359	0.542	FES	NA	chr15_90897856_T_C|0.000132|1	0.624	NA	NA	NA
chr11_1866576_T_A	true	11	7.770000000000001e-18	17.1	0.0734	0.9508906959480359	0.575	LSP1	chr11_1866576_T_A|missense_variant|1	chr11_1865986_T_C|0.352|0.997;chr11_1866576_T_A|0.453|1;chr11_1868019_C_T|0.153|0.941	8.49	diastolic blood pressure|0.997;alcohol drinking|0.997;cardiovascular disease|0.997	diastolic blood pressure|0.997;cardiovascular disease|0.997;alcohol drinking|0.997;smoking status measurement|0.14;systolic blood pressure|0.14;pulse pressure measurement|0.14;mean arterial pressure|0.14	NA
chr10_114032303_G_A	false	10	8.37e-18	17.1	0.0834	1.0447818150140915	0.747	NA	NA	chr10_114032303_G_A|0.000729|1	0.0735	systolic blood pressure|1;alcohol drinking|1;alcohol consumption measurement|1;mean arterial pressure|1	alcohol consumption measurement|1;systolic blood pressure|1;mean arterial pressure|1;alcohol drinking|1	NA
chr6_150663295_C_T	true	6	3e-17	16.5	-0.135	1.2080983375886525	0.076	PLEKHG1	NA	chr6_150663295_C_T|0.191|1;chr6_150663605_G_A|0.106|0.998;chr6_150668562_A_G|0.0619|0.992;chr6_150671234_T_A|0.104|0.986;chr6_150675899_T_C|0.125|0.988;chr6_150676265_C_T|0.126|0.988;chr6_150681235_T_C|0.142|0.988;chr6_150683634_G_C|0.133|0.985	10.9	systolic blood pressure|0.998;coronary artery disease|0.988;hematocrit|0.988;red blood cell distribution width|0.986;diastolic blood pressure|0.985;smoking status measurement|0.985	systolic blood pressure|0.998;hematocrit|0.988;coronary artery disease|0.988;red blood cell distribution width|0.986;smoking status measurement|0.985;diastolic blood pressure|0.985;alcohol consumption measurement|0.875;cardiovascular disease|0.875;mean arterial pressure|0.875;Diuretic use measurement|0.694;Calcium channel blocker use measurement|0.694;Agents acting on the renin-angiotensin system use measurement|0.691	NA
chr12_54047714_C_T	true	12	1.64e-16	15.8	-0.0719	1.3384581659192825	0.382	HOXC4	NA	chr12_54040493_C_T|0.0453|0.958;chr12_54047714_C_T|0.499|1;chr12_54049957_AAAC_A|0.407|0.941	7.64	systolic blood pressure|1;mean arterial pressure|1;pulse pressure measurement|1;cardiovascular disease|1	systolic blood pressure|1;mean arterial pressure|1;pulse pressure measurement|1;cardiovascular disease|1;type II diabetes mellitus|0.801;triglyceride measurement|0.801;diastolic blood pressure|0.679;alcohol drinking|0.679;Agents acting on the renin-angiotensin system use measurement|0.613;FEV/FEC ratio|0.525;BMI-adjusted waist circumference|0.475;leukocyte count|0.458;BMI-adjusted waist-hip ratio|0.458;waist-hip ratio|0.458;spine bone size|0.445;physical activity measurement|0.445;heel bone mineral density|0.303	NA
chr11_1899025_T_G	false	11	8.75e-16	15.1	0.0809	0.8859532674716429	0.23399999999999999	LINC01150	NA	chr11_1899025_T_G|0.0423|1	0.981	pulse pressure measurement|1;diastolic blood pressure|1;smoking status measurement|1;systolic blood pressure|1;alcohol drinking|1;mean arterial pressure|1	pulse pressure measurement|1;diastolic blood pressure|1;smoking status measurement|1;systolic blood pressure|1;alcohol drinking|1;mean arterial pressure|1	NA
chr16_53792116_T_C	true	16	1.34e-15	14.9	0.0684	0.9821998652420412	0.413	FTO	NA	chr16_53765357_GACC_G|0.0254|0.93;chr16_53765366_G_GT|0.0254|0.93;chr16_53765367_G_T|0.0254|0.93;chr16_53765384_C_T|0.0254|0.93;chr16_53765391_C_T|0.0254|0.93;chr16_53765595_G_A|0.0258|0.927;chr16_53765935_G_A|0.0256|0.93;chr16_53765993_A_G|0.0256|0.93;chr16_53766065_T_G|0.0228|0.93;chr16_53766073_T_A|0.0256|0.93;chr16_53766288_C_T|0.0256|0.93;chr16_53766656_G_A|0.0245|0.93;chr16_53766717_C_G|0.0257|0.93;chr16_53766842_G_A|0.0244|0.93;chr16_53767042_T_C|0.00373|0.89;chr16_53767431_C_A|0.0256|0.93;chr16_53767637_C_T|0.022|0.929;chr16_53768073_C_T|0.0254|0.93;chr16_53768582_C_T|0.00599|0.889;chr16_53769275_A_T|0.0257|0.93;chr16_53769311_G_A|0.00621|0.89;chr16_53771295_C_A|0.0345|0.93;chr16_53772541_A_G|0.00725|0.888;chr16_53775211_C_T|0.00397|0.89;chr16_53775335_G_A|0.0305|0.931;chr16_53776774_T_C|0.0032|0.955;chr16_53777031_C_T|0.00491|0.954;chr16_53777876_A_G|0.00326|0.955;chr16_53778521_T_C|0.00327|0.955;chr16_53779455_T_G|0.00413|0.955;chr16_53779538_A_T|0.00345|0.955;chr16_53781523_T_C|0.00326|0.955;chr16_53782363_C_A|0.00332|0.955;chr16_53782840_A_G|0.00318|0.955;chr16_53782926_G_A|0.00323|0.955;chr16_53784255_T_C|0.0202|0.996;chr16_53784548_G_T|0.0039|0.955;chr16_53784901_A_G|0.02|0.996;chr16_53785257_T_C|0.00313|0.955;chr16_53785286_G_C|0.00283|0.955;chr16_53786901_A_G|0.0187|0.996;chr16_53787213_A_G|0.0034|0.955;chr16_53787385_T_C|0.0031|0.954;chr16_53787501_T_C|0.0195|0.996;chr16_53787950_C_T|0.0187|0.996;chr16_53788475_C_T|0.0034|0.955;chr16_53788528_G_A|0.00316|0.954;chr16_53791576_C_T|0.031|0.996;chr16_53791993_G_A|0.0059|0.956;chr16_53792116_T_C|0.0839|1;chr16_53793267_C_G|0.0556|0.998;chr16_53793567_A_G|0.00766|0.957;chr16_53794050_A_G|0.00761|0.957;chr16_53794154_C_T|0.00719|0.957;chr16_53796540_A_G|0.00969|0.952;chr16_53796553_A_G|0.00732|0.951;chr16_53796579_T_C|0.00969|0.952;chr16_53796955_T_A|0.00969|0.952;chr16_53797234_C_T|0.00724|0.95;chr16_53797859_G_T|0.00849|0.95	9.4	alcohol use disorder measurement|0.996;longitudinal alcohol consumption measurement|0.996;obesity|0.996;physical activity measurement|0.996;body mass index|0.996;lean body mass|0.957;type II diabetes mellitus|0.955;age at menarche|0.955;urate measurement|0.955;low density lipoprotein cholesterol measurement|0.955;heel bone mineral density|0.955;Breast cancer|0.955;leptin measurement|0.955;blood urea nitrogen measurement|0.955;chronic obstructive pulmonary disease|0.955;body weight|0.955;age at assessment|0.955;sex interaction measurement|0.955;high density lipoprotein cholesterol measurement|0.955;red blood cell distribution width|0.954;waist-hip ratio|0.951;metabolic syndrome|0.93;hip circumference|0.93;pulse pressure measurement|0.93;alcohol drinking|0.93;obese body mass index status|0.93;coffee consumption measurement|0.927;energy intake|0.89;fat intake measurement|0.89;longitudinal BMI measurement|0.89;diet measurement|0.89;waist circumference|0.89;base metabolic rate measurement|0.89;body fat percentage|0.89;alcohol consumption measurement|0.89;grip strength measurement|0.89;Type 2 Diabetes Mellitus|0.89;sugar sweetened beverage consumption measurement|0.89;body fat distribution|0.89;systolic blood pressure|0.89;breast carcinoma|0.89;Agents acting on the renin-angiotensin system use measurement|0.89;chronotype measurement|0.89;alcohol dependence|0.89;HMG CoA reductase inhibitor use measurement|0.89;smoking status measurement|0.889;mean arterial pressure|0.889;sodium measurement|0.889;diastolic blood pressure|0.889	alcohol use disorder measurement|0.996;physical activity measurement|0.996;longitudinal alcohol consumption measurement|0.996;obesity|0.996;body mass index|0.996;lean body mass|0.957;mortality|0.956;diabetes mellitus|0.956;heart failure|0.956;systolic blood pressure|0.956;hematocrit|0.956;diastolic blood pressure|0.956;cancer|0.956;high density lipoprotein cholesterol measurement|0.956;atrial fibrillation|0.956;coronary heart disease|0.956;ventricular rate measurement|0.956;stroke|0.956;triglyceride measurement|0.956;total cholesterol measurement|0.956;type II diabetes mellitus|0.956;alcohol dependence|0.956;age at menarche|0.956;glucose measurement|0.956;fat body mass|0.956;urate measurement|0.955;low density lipoprotein cholesterol measurement|0.955;body weight|0.955;chronic obstructive pulmonary disease|0.955;blood urea nitrogen measurement|0.955;leptin measurement|0.955;Breast cancer|0.955;heel bone mineral density|0.955;age at assessment|0.955;sex interaction measurement|0.955;red blood cell distribution width|0.954;waist-hip ratio|0.951;sugar consumption measurement|0.95;non-grapefruit juice consumption measurement|0.95;leukocyte count|0.95;diet measurement|0.95;pulse pressure measurement|0.93;alcohol drinking|0.93;obese body mass index status|0.93;metabolic syndrome|0.93;hip circumference|0.93;coffee consumption measurement|0.927;sugar sweetened beverage consumption measurement|0.89;body fat distribution|0.89;Agents acting on the renin-angiotensin system use measurement|0.89;energy intake|0.89;alcohol consumption measurement|0.89;chronotype measurement|0.89;HMG CoA reductase inhibitor use measurement|0.89;Type 2 Diabetes Mellitus|0.89;breast carcinoma|0.89;grip strength measurement|0.89;longitudinal BMI measurement|0.89;body fat percentage|0.89;fat intake measurement|0.89;waist circumference|0.89;base metabolic rate measurement|0.89;smoking status measurement|0.889;sodium measurement|0.889;mean arterial pressure|0.889;smoking behavior|0.873;HbA1c measurement|0.873;C-reactive protein measurement|0.873;height-adjusted body mass index|0.873;adolescent idiopathic scoliosis|0.827;risky sexual behaviour measurement|0.804;Calcium channel blocker use measurement|0.8;appendicular lean mass|0.727;urolithiasis|0.582	NA
chr5_61698068_T_G	true	5	1.5099999999999999e-15	14.8	0.264	50.9559408	0.0171	RP11-2O17.2	NA	chr5_61698068_T_G|0.573|1;chr5_61708983_A_G|0.417|0.999	8.53	NA	NA	NA
chr19_2588425_A_C	true	19	3.2e-15	14.5	-0.179	2.0332681124378107	0.0371	GNG7	NA	chr19_2588425_A_C|1|1	6.76	systolic blood pressure|1	systolic blood pressure|1	NA
chr1_112504108_GT_G	true	1	6.909999999999999e-15	14.2	0.0795	0.9681867877178808	0.779	WNT2B	NA	chr1_112480690_G_C|0.0128|0.643;chr1_112485180_T_A|0.0215|0.68;chr1_112491665_T_C|0.00535|0.498;chr1_112496173_A_G|0.219|0.724;chr1_112497371_G_A|0.25|0.724;chr1_112498210_G_C|0.0327|0.773;chr1_112499936_T_C|0.0237|0.777;chr1_112504108_GT_G|0.363|1;chr1_112542575_C_A|0.0118|0.25;chr1_112688136_A_G|0.00667|0.32;chr1_112701811_T_C|0.00651|0.315	1.7	Diuretic use measurement|0.32;diastolic blood pressure|0.32;alcohol drinking|0.32;systolic blood pressure|0.32;mean arterial pressure|0.32	hypertension|0.214;alcohol drinking|0.32;mean arterial pressure|0.32;diastolic blood pressure|0.32;Diuretic use measurement|0.32;systolic blood pressure|0.32;brain volume measurement|0.228;visual cortical surface area measurement|0.228;cortical surface area measurement|0.228;vital capacity|0.228;chronotype measurement|0.198;heel bone mineral density|0.151	NA
chr19_11397501_G_A	true	19	3.66e-14	13.4	0.098	1.284965132662397	0.121	RGL3	chr19_11397501_G_A|missense_variant|1	chr19_11386922_T_C|0.0909|0.865;chr19_11397501_G_A|0.851|1;chr19_11410528_T_A|0.0435|0.677	1.95	NA	systolic blood pressure|0.563	NA
chr7_151011001_A_G	false	7	4.51e-14	13.3	-0.0885	1.081295588555214	0.847	NOS3	NA	chr7_151011001_A_G|2.91e-05|1	0.158	NA	NA	NA
chr4_155718022_G_A	true	4	4.69e-14	13.3	-0.0668	0.9429690590631364	0.34600000000000003	GUCY1A3	NA	chr4_155713794_C_G|0.0706|1;chr4_155715175_C_CT|0.0709|1;chr4_155716990_C_T|0.0703|1;chr4_155717715_A_G|0.0697|1;chr4_155718022_G_A|0.0815|1;chr4_155718694_A_G|0.0528|0.917;chr4_155719895_G_A|0.0544|0.916;chr4_155720860_A_G|0.0569|0.916;chr4_155721091_T_C|0.0571|0.916;chr4_155721118_T_A|0.0571|0.916;chr4_155721181_TTGGGCC_T|0.0572|0.916;chr4_155721189_AGGGGTTCG_A|0.0572|0.916;chr4_155721648_T_C|0.0575|0.916;chr4_155722024_T_A|0.0576|0.916;chr4_155722651_C_T|0.0584|0.916;chr4_155722863_C_A|0.0591|0.916	8.08	NA	hypertension|0.35;coronary artery disease|0.631;diastolic blood pressure|0.631;systolic blood pressure|0.63;Agents acting on the renin-angiotensin system use measurement|0.63;Diuretic use measurement|0.58;myocardial infarction|0.572;Calcium channel blocker use measurement|0.572;lymphocyte count|0.522;alcohol consumption measurement|0.521;alcohol drinking|0.521;mean arterial pressure|0.521;smoking status measurement|0.506;leukocyte count|0.506;Beta blocking agent use measurement|0.437;myeloid white cell count|0.403	NA
chr17_61404808_C_G	true	17	6.14e-14	13.2	0.0707	1.002442950518441	0.722	TBX2	NA	chr17_61398281_C_T|0.0416|0.996;chr17_61400993_G_C|0.0419|0.996;chr17_61401283_G_A|0.0544|0.999;chr17_61401415_G_C|0.0551|0.999;chr17_61404804_GC_G|0.069|0.999;chr17_61404808_C_G|0.0721|1;chr17_61404812_G_A|0.0638|0.999;chr17_61406405_C_T|0.0591|0.998;chr17_61406955_A_G|0.0417|0.996;chr17_61407472_C_T|0.068|0.998;chr17_61407656_G_A|0.0641|0.999;chr17_61407759_G_A|0.064|0.999;chr17_61408032_C_T|0.0642|0.999;chr17_61408194_C_T|0.0642|0.999;chr17_61409438_A_G|0.0641|0.998;chr17_61412874_C_T|0.0682|0.998	4.97	hypertension|0.998;Mean Arterial Pressure|0.999;mean arterial pressure|0.999;systolic blood pressure|0.999;diastolic blood pressure|0.998;creatinine measurement|0.998;potassium measurement|0.996;chloride measurement|0.996	hypertension|0.998;mean arterial pressure|0.999;systolic blood pressure|0.999;Mean Arterial Pressure|0.999;diastolic blood pressure|0.998;creatinine measurement|0.998;potassium measurement|0.996;chloride measurement|0.996;Diuretic use measurement|0.531;Abnormality of refraction|0.531;refractive error measurement|0.531;cardiovascular disease|0.531;Agents acting on the renin-angiotensin system use measurement|0.473;hemoglobin measurement|0.459;gout|0.459;hematocrit|0.428;renal system measurement|0.428;glomerular filtration rate|0.428;erythrocyte count|0.428;urate measurement|0.428;chronic kidney disease|0.428;red blood cell density measurement|0.428;uric acid measurement|0.428;calcium measurement|0.428;blood metabolite measurement|0.406;protein measurement|0.406;amino acid measurement|0.406;urolithiasis|0.406;pulse pressure measurement|0.403;heel bone mineral density|0.325;waist-hip ratio|0.207;BMI-adjusted waist circumference|0.139	NA
chr10_103089359_G_C	true	10	6.99e-14	13.2	-0.11	0.7535318518518518	0.0915	NT5C2	NA	chr10_102831636_G_T|0.0047|0.767;chr10_102834750_A_G|0.00478|0.767;chr10_102836092_G_C|0.00466|0.768;chr10_102844806_C_T|0.00476|0.768;chr10_102845159_T_G|0.007|0.766;chr10_102853184_G_A|0.00481|0.768;chr10_102853263_G_A|0.00481|0.768;chr10_102854593_C_T|0.006|0.767;chr10_102856906_T_C|0.00484|0.786;chr10_102866213_C_T|0.00422|0.788;chr10_102878723_C_T|0.0046|0.878;chr10_102888725_CTT_C|0.00456|0.878;chr10_102892566_C_T|0.00508|0.875;chr10_102895593_T_C|0.00443|0.878;chr10_102897491_A_G|0.00426|0.878;chr10_102897712_C_A|0.00426|0.878;chr10_102900095_T_C|0.00421|0.878;chr10_102900247_A_G|0.00414|0.878;chr10_102900931_A_G|0.00421|0.878;chr10_102901488_C_T|0.00421|0.878;chr10_102902124_C_A|0.00421|0.878;chr10_102902458_C_T|0.00421|0.878;chr10_102907000_G_A|0.00436|0.878;chr10_102917369_C_T|0.00449|0.878;chr10_102921386_A_G|0.00448|0.878;chr10_102922845_G_A|0.00448|0.878;chr10_102924787_G_A|0.00448|0.878;chr10_102925542_C_A|0.00603|0.878;chr10_102929908_A_T|0.00472|0.878;chr10_102934897_G_A|0.00473|0.878;chr10_102937233_ATGATAGCCC_A|0.00473|0.878;chr10_102937759_G_A|0.00473|0.878;chr10_102947259_A_T|0.00473|0.878;chr10_102953319_C_T|0.00473|0.878;chr10_102953356_A_C|0.00473|0.878;chr10_102953405_C_T|0.00473|0.878;chr10_102959339_G_A|0.00456|0.878;chr10_102961369_A_T|0.00473|0.878;chr10_102961914_TATTAA_T|0.00466|0.878;chr10_102962205_G_C|0.00473|0.878;chr10_102963863_T_C|0.00466|0.878;chr10_102969492_G_A|0.00479|0.879;chr10_102977940_T_TG|0.00482|0.879;chr10_102979422_T_C|0.00484|0.879;chr10_102981274_C_T|0.00487|0.879;chr10_102988252_G_A|0.00496|0.879;chr10_103013607_C_T|0.00434|0.88;chr10_103029718_T_G|0.0117|0.901;chr10_103029823_G_A|0.00985|0.901;chr10_103032493_CAG_C|0.0105|0.901;chr10_103033891_T_C|0.0104|0.901;chr10_103034147_C_T|0.0104|0.901;chr10_103047141_G_C|0.0106|0.901;chr10_103056070_A_G|0.0109|0.9;chr10_103064630_G_A|0.0114|0.901;chr10_103065908_C_G|0.0101|0.9;chr10_103068269_GGAGGCCAAGACAGT_G|0.0118|0.901;chr10_103076162_C_T|0.012|0.901;chr10_103081210_A_G|0.0126|0.901;chr10_103081722_C_T|0.0126|0.901;chr10_103086421_T_C|0.0112|0.899;chr10_103088673_C_T|0.0126|0.901;chr10_103089359_G_C|0.137|1;chr10_103091078_A_G|0.0126|0.901;chr10_103091544_G_T|0.0212|0.9;chr10_103092132_T_C|0.0126|0.901;chr10_103092155_C_T|0.0126|0.901;chr10_103096405_G_A|0.0126|0.901;chr10_103097007_CAA_C|0.0126|0.901;chr10_103097766_A_C|0.00721|0.891;chr10_103104857_C_G|0.00728|0.898;chr10_103104921_G_A|0.0126|0.901;chr10_103107929_C_T|0.0127|0.901;chr10_103109281_T_C|0.0129|0.901;chr10_103111447_A_G|0.0128|0.901;chr10_103111522_T_G|0.0128|0.901;chr10_103113495_TA_T|0.0155|0.901;chr10_103114004_G_C|0.0128|0.901;chr10_103117545_T_C|0.0128|0.901;chr10_103123580_A_G|0.0128|0.901;chr10_103124451_T_C|0.0128|0.901;chr10_103126617_G_A|0.0128|0.901;chr10_103138144_T_C|0.0129|0.901;chr10_103138369_C_T|0.0129|0.901;chr10_103138580_C_T|0.0129|0.901;chr10_103141274_A_G|0.0129|0.901;chr10_103141734_T_C|0.0145|0.897;chr10_103146454_T_C|0.0138|0.901;chr10_103151202_G_A|0.0129|0.901;chr10_103153896_G_A|0.0129|0.901;chr10_103154183_T_C|0.00598|0.892;chr10_103169157_T_A|0.0129|0.901;chr10_103169959_T_C|0.0129|0.901;chr10_103171827_G_C|0.0129|0.901;chr10_103179458_T_C|0.00671|0.897;chr10_103181189_T_C|0.00672|0.897;chr10_103182487_T_G|0.00672|0.897;chr10_103186066_G_A|0.00618|0.898;chr10_103192742_C_T|0.00609|0.898	6.34	hypertension|0.901;schizophrenia|1;systolic blood pressure|0.901;body mass index|0.901;anorexia nervosa|0.901;obsessive-compulsive disorder|0.901;attention deficit hyperactivity disorder|0.901;Tourette syndrome|0.901;unipolar depression|0.901;autism spectrum disorder|0.901;bipolar disorder|0.901;coronary artery disease|0.901;Agents acting on the renin-angiotensin system use measurement|0.901;cardiovascular disease|0.901;mean arterial pressure|0.901;pulse pressure measurement|0.901;diastolic blood pressure|0.901;smoking status measurement|0.899;anxiety|0.898;birth weight|0.897;visceral adipose tissue measurement|0.878;coronary heart disease|0.878;brain aneurysm|0.878;large artery stroke|0.878;insomnia measurement|0.878;wellbeing measurement|0.786;depressive symptom measurement|0.767;neuroticism measurement|0.767;red blood cell density measurement|0.767	hypertension|0.901;schizophrenia|1;anorexia nervosa|0.901;obsessive-compulsive disorder|0.901;mean arterial pressure|0.901;autism spectrum disorder|0.901;attention deficit hyperactivity disorder|0.901;pulse pressure measurement|0.901;systolic blood pressure|0.901;Agents acting on the renin-angiotensin system use measurement|0.901;diastolic blood pressure|0.901;body mass index|0.901;Tourette syndrome|0.901;unipolar depression|0.901;coronary artery disease|0.901;cardiovascular disease|0.901;bipolar disorder|0.901;smoking status measurement|0.899;anxiety|0.898;birth weight|0.897;large artery stroke|0.878;coronary heart disease|0.878;brain aneurysm|0.878;visceral adipose tissue measurement|0.878;insomnia measurement|0.878;wellbeing measurement|0.786;red blood cell density measurement|0.767;depressive symptom measurement|0.767;neuroticism measurement|0.767;urinary arsenic measurement|0.656;monocyte count|0.485;body height|0.444;red blood cell distribution width|0.238;intelligence|0.237;self reported educational attainment|0.237;hematocrit|0.237;smoking behavior|0.179;alcohol drinking|0.176;alcohol consumption measurement|0.176;smoking initiation|0.165;reticulocyte count|0.165;feeling nervous measurement|0.133;worry measurement|0.133;brain volume measurement|0.123;intracranial volume measurement|0.123;systemic lupus erythematosus|0.122;household income|0.109;hemoglobin measurement|0.104	NA
chr10_94256036_C_G	true	10	7.12e-14	13.1	-0.0667	0.7601418717895176	0.34600000000000003	PLCE1	chr10_94279840_G_C|missense_variant|0.993	chr10_94254865_C_G|0.145|0.996;chr10_94256036_C_G|0.206|1;chr10_94263320_T_C|0.157|0.996;chr10_94266427_CA_C|0.156|0.996;chr10_94278929_G_A|0.155|0.995;chr10_94279840_G_C|0.182|0.993	20.3	migraine disorder|0.996;BMI-adjusted waist circumference|0.996;cardiovascular disease|0.996;systolic blood pressure|0.996;Calcium channel blocker use measurement|0.996;lean body mass|0.995;appendicular lean mass|0.995;platelet count|0.995	Calcium channel blocker use measurement|0.996;cardiovascular disease|0.996;BMI-adjusted waist circumference|0.996;migraine disorder|0.996;systolic blood pressure|0.996;platelet count|0.995;lean body mass|0.995;appendicular lean mass|0.995;cup-to-disc ratio measurement|0.709;optic cup area measurement|0.709;esophageal squamous cell carcinoma|0.557;esophageal carcinoma|0.557;gastric carcinoma|0.534;personality trait|0.497;Dengue Hemorrhagic Fever|0.49;body height|0.373;blood metabolite measurement|0.292;urinary metabolite measurement|0.286;chronic kidney disease|0.286;monocyte count|0.21;basophil count|0.21;birth weight|0.142;parental genotype effect measurement|0.142	NA
chr12_53058093_C_T	true	12	4.320000000000001e-13	12.4	0.218	12.609700695652178	0.0209	TNS2	NA	chr12_53058093_C_T|0.924|1;chr12_53063801_C_T|0.044|0.937	4.68	NA	NA	NA
chr5_128536057_C_T	true	5	4.79e-13	12.3	0.0667	0.8926346188133141	0.297	FBN2	NA	chr5_128465365_A_G|0.00885|0.768;chr5_128467143_T_C|0.00862|0.768;chr5_128479760_G_C|0.0051|0.769;chr5_128481856_T_C|0.00565|0.769;chr5_128484840_A_G|0.00537|0.769;chr5_128486852_A_T|0.00536|0.77;chr5_128488835_A_C|0.00504|0.77;chr5_128488892_A_G|0.00504|0.77;chr5_128489136_A_AT|0.00504|0.77;chr5_128489288_A_C|0.00504|0.77;chr5_128490402_A_C|0.00505|0.77;chr5_128491000_A_G|0.00505|0.77;chr5_128491469_A_G|0.00505|0.77;chr5_128492624_T_G|0.00505|0.77;chr5_128495215_A_AC|0.00505|0.77;chr5_128495457_T_A|0.00505|0.77;chr5_128496854_A_G|0.00531|0.77;chr5_128497602_C_T|0.00505|0.77;chr5_128497729_C_T|0.00506|0.77;chr5_128501806_T_A|0.00569|0.77;chr5_128502602_AC_A|0.0057|0.77;chr5_128503083_TC_T|0.0057|0.77;chr5_128503813_A_G|0.00571|0.77;chr5_128504207_C_G|0.00571|0.77;chr5_128505298_G_C|0.00571|0.77;chr5_128506726_C_T|0.00571|0.77;chr5_128507515_C_T|0.00573|0.77;chr5_128507845_C_T|0.00553|0.77;chr5_128525919_C_T|0.0102|0.824;chr5_128528669_A_G|0.0104|0.824;chr5_128536057_C_T|0.0809|1;chr5_128537912_T_C|0.0555|0.997;chr5_128538114_C_T|0.0643|0.997;chr5_128540536_G_A|0.00509|0.653;chr5_128542052_G_A|0.0669|0.997;chr5_128545873_C_T|0.0682|0.997;chr5_128555665_T_C|0.0249|0.985;chr5_128557617_C_CA|0.0685|0.997;chr5_128562124_C_T|0.0692|0.997;chr5_128562825_A_G|0.0701|0.997;chr5_128569918_G_C|0.066|0.997;chr5_128570836_C_T|0.0667|0.997;chr5_128574030_T_C|0.0676|0.997	7.39	Abnormality of refraction|1;Calcium channel blocker use measurement|0.997;systolic blood pressure|0.77	Abnormality of refraction|1;Calcium channel blocker use measurement|0.997;Diuretic use measurement|0.843;cardiovascular disease|0.818;systolic blood pressure|0.818;Beta blocking agent use measurement|0.818;pulse pressure measurement|0.53;gut microbiome measurement|0.51;Agents acting on the renin-angiotensin system use measurement|0.257;heel bone mineral density|0.227	NA
chr17_60624352_A_G	true	17	5.429999999999999e-13	12.3	-0.18899999999999997	51.26251485714287	0.0274	PPM1D	NA	chr17_60172281_G_A|0.0335|0.863;chr17_60247350_T_C|0.0338|0.866;chr17_60257053_G_A|0.0306|0.864;chr17_60389590_T_C|0.032|0.866;chr17_60394964_G_A|0.032|0.866;chr17_60523271_T_C|0.107|0.931;chr17_60532126_C_CA|0.0486|0.888;chr17_60624352_A_G|0.339|1;chr17_60635944_G_C|0.0989|0.961;chr17_60724183_A_T|0.0419|0.895;chr17_60923456_T_C|0.0229|0.873;chr17_61004985_A_T|0.025|0.868;chr17_61020538_G_A|0.0251|0.868;chr17_61035279_C_A|0.0251|0.868;chr17_61146845_C_T|0.0254|0.868;chr17_61146852_G_A|0.0254|0.868;chr17_61152540_T_TA|0.0247|0.868	2.39	NA	NA	NA
chr7_106773623_T_G	true	7	9.109999999999999e-13	12	0.0661	1.5321522621184918	0.297	RP5-884M6.1	NA	chr7_106770331_G_A|0.296|0.998;chr7_106771412_T_C|0.299|0.999;chr7_106773623_T_G|0.356|1	6.41	pulse pressure measurement|0.999;cardiovascular disease|0.999;Diuretic use measurement|0.999;carotid atherosclerosis|0.999;systolic blood pressure|0.999;smoking status measurement|0.999	pulse pressure measurement|0.999;cardiovascular disease|0.999;Diuretic use measurement|0.999;carotid atherosclerosis|0.999;systolic blood pressure|0.999;smoking status measurement|0.999;atherosclerosis|0.909;Agents acting on the renin-angiotensin system use measurement|0.902;Calcium channel blocker use measurement|0.901	NA
chr5_32832368_C_A	true	5	9.45e-13	12	0.061	1.0000943926742198	0.585	NA	NA	chr5_32814922_A_G|0.0525|0.991;chr5_32818967_T_C|0.0505|0.991;chr5_32820446_T_G|0.0541|0.992;chr5_32820447_T_C|0.0541|0.992;chr5_32821105_T_C|0.0587|0.991;chr5_32828740_T_C|0.0674|0.994;chr5_32829869_C_G|0.0965|0.998;chr5_32830415_T_C|0.091|0.998;chr5_32831564_T_C|0.116|0.998;chr5_32831833_T_C|0.166|0.998;chr5_32832368_C_A|0.182|1	5.99	hypertension|0.998;systolic blood pressure|0.998;body height|0.998;mean arterial pressure|0.998;pulse pressure measurement|0.998;diastolic blood pressure|0.998;Beta blocking agent use measurement|0.998;Agents acting on the renin-angiotensin system use measurement|0.998;BMI-adjusted hip circumference|0.991;smoking status measurement|0.991	hypertension|0.998;systolic blood pressure|0.998;mean arterial pressure|0.998;Agents acting on the renin-angiotensin system use measurement|0.998;Beta blocking agent use measurement|0.998;diastolic blood pressure|0.998;body height|0.998;pulse pressure measurement|0.998;smoking status measurement|0.991;BMI-adjusted hip circumference|0.991;alcohol consumption measurement|0.293;alcohol drinking|0.293;BMI-adjusted waist circumference|0.223;waist-hip ratio|0.209;BMI-adjusted waist-hip ratio|0.209;lean body mass|0.134	NA
chr10_105610797_C_T	true	10	1.08e-12	12	0.358	0.7168641120000001	0.007109999999999999	NA	NA	chr10_104761217_A_C|0.0882|0.798;chr10_105045593_A_T|0.246|0.867;chr10_105124496_CTTTTTAGCT_C|0.024|0.748;chr10_105135184_C_T|0.0238|0.748;chr10_105143590_C_G|0.0259|0.749;chr10_105610797_C_T|0.558|1	5.7	diastolic blood pressure|0.748;systolic blood pressure|0.748	diastolic blood pressure|0.748;systolic blood pressure|0.748;Calcium channel blocker use measurement|0.409	NA
chr7_27279858_G_T	true	7	1.52e-12	11.8	0.0872	1.4965507169117649	0.136	NA	NA	chr7_27276298_A_C|0.0454|0.995;chr7_27277021_A_G|0.0341|0.994;chr7_27279420_G_A|0.101|1;chr7_27279858_G_T|0.102|1;chr7_27280056_G_A|0.00826|0.831;chr7_27280700_T_C|0.0965|0.999;chr7_27281931_T_A|0.0965|0.999;chr7_27283985_T_G|0.00617|0.656;chr7_27284577_T_G|0.00617|0.656;chr7_27284750_G_A|0.0965|0.999;chr7_27285694_T_C|0.0965|0.999;chr7_27286674_C_G|0.00584|0.833;chr7_27288568_C_G|0.0965|0.999;chr7_27289310_C_T|0.00617|0.656;chr7_27289554_C_G|0.0965|0.999;chr7_27292529_C_T|0.00637|0.656;chr7_27293543_A_G|0.00637|0.656;chr7_27310988_A_G|0.0469|0.972	4	mean arterial pressure|1;alcohol drinking|1;Agents acting on the renin-angiotensin system use measurement|1;diastolic blood pressure|0.999;Calcium channel blocker use measurement|0.999;Diuretic use measurement|0.999	hypertension|0.308;mean arterial pressure|1;alcohol drinking|1;Agents acting on the renin-angiotensin system use measurement|1;Calcium channel blocker use measurement|0.999;diastolic blood pressure|0.999;Diuretic use measurement|0.999;systolic blood pressure|0.308;pulse pressure measurement|0.308;heel bone mineral density|0.131	NA
chr19_7316206_C_A	true	19	1.75e-12	11.8	0.0619	NA	0.5760000000000001	NA	NA	chr19_7316206_C_A|0.241|1;chr19_7324644_T_C|0.0303|0.873;chr19_7324647_A_T|0.0357|0.876;chr19_7324654_T_C|0.0357|0.876;chr19_7324764_A_G|0.0355|0.876;chr19_7325055_A_G|0.0381|0.876;chr19_7325629_T_C|0.0383|0.876;chr19_7325778_TA_T|0.0381|0.876;chr19_7325968_C_T|0.0385|0.876;chr19_7326036_T_C|0.0267|0.875;chr19_7326037_G_A|0.0267|0.875;chr19_7326106_A_C|0.0383|0.876;chr19_7326128_G_A|0.0381|0.876;chr19_7326262_T_C|0.0386|0.876;chr19_7326405_T_A|0.0385|0.876;chr19_7326619_C_G|0.0388|0.876;chr19_7326961_C_G|0.037|0.875;chr19_7327041_G_A|0.0268|0.874;chr19_7327224_T_C|0.0394|0.876;chr19_7327287_C_A|0.0392|0.876;chr19_7328659_T_C|0.0421|0.875	5.66	NA	NA	NA
chr6_78948818_T_C	true	6	2e-12	11.7	0.0604	1.0343065666272189	0.41	PHIP	NA	chr6_78773529_T_C|0.00303|0.894;chr6_78774669_C_A|0.00311|0.894;chr6_78797950_A_T|0.00205|0.908;chr6_78799650_A_C|0.00211|0.908;chr6_78801277_A_C|0.00232|0.907;chr6_78829074_G_A|0.007|0.982;chr6_78847154_A_G|0.0118|0.984;chr6_78848447_T_C|0.0118|0.984;chr6_78856600_A_G|0.0118|0.984;chr6_78858165_A_G|0.0118|0.984;chr6_78865574_C_G|0.0117|0.984;chr6_78865575_C_T|0.0117|0.984;chr6_78869485_A_C|0.0173|0.99;chr6_78875506_TAAAG_T|0.0134|0.993;chr6_78877456_A_G|0.0134|0.993;chr6_78887644_C_T|0.0132|0.993;chr6_78901788_G_A|0.0129|0.993;chr6_78905491_G_A|0.00138|0.821;chr6_78906076_G_T|0.0131|0.993;chr6_78918026_A_T|0.0131|0.993;chr6_78928208_T_C|0.0126|0.993;chr6_78933392_C_T|0.0269|0.997;chr6_78933487_C_T|0.00156|0.827;chr6_78936858_A_G|0.00155|0.827;chr6_78937690_GT_G|0.0266|0.997;chr6_78944968_G_GA|0.0266|0.997;chr6_78945760_G_A|0.00148|0.827;chr6_78947674_G_A|0.00128|0.826;chr6_78947951_TC_TCC|0.00339|0.983;chr6_78948818_T_C|0.0459|1;chr6_78949453_A_G|0.00155|0.827;chr6_78951408_T_C|0.00155|0.827;chr6_78954723_T_C|0.00155|0.827;chr6_78955031_T_C|0.00155|0.827;chr6_78962416_G_T|0.00155|0.827;chr6_78962805_A_G|0.00155|0.827;chr6_78964459_G_A|0.0267|0.997;chr6_78964545_C_T|0.00156|0.827;chr6_78965212_T_C|0.025|0.996;chr6_78966611_A_T|0.00161|0.827;chr6_78968494_G_A|0.00188|0.825;chr6_78968731_AAATT_A|0.00161|0.827;chr6_78971934_G_A|0.0016|0.827;chr6_78972754_G_A|0.0274|0.997;chr6_78972850_G_A|0.0016|0.827;chr6_78974174_A_G|0.00146|0.826;chr6_78974623_C_G|0.0249|0.996;chr6_78974700_G_A|0.00148|0.827;chr6_78976256_GA_G|0.0241|0.996;chr6_78976614_G_A|0.0019|0.825;chr6_78977587_G_GACCTTCAAGC|0.00158|0.812;chr6_78979733_C_T|0.00152|0.827;chr6_78980573_G_A|0.00152|0.827;chr6_78980859_C_T|0.00152|0.827;chr6_78985312_C_T|0.00153|0.827;chr6_78986948_GAAT_G|0.0018|0.827;chr6_78988663_C_T|0.0018|0.827;chr6_78989094_C_CA|0.0018|0.827;chr6_78990120_C_T|0.0284|0.996;chr6_78992255_G_A|0.0018|0.827;chr6_78993079_C_T|0.0284|0.996;chr6_78996128_C_T|0.00176|0.827;chr6_78998206_C_T|0.0277|0.996;chr6_79001089_C_T|0.0277|0.996;chr6_79005150_T_C|0.00193|0.827;chr6_79009078_T_G|0.00193|0.827;chr6_79009906_C_G|0.00193|0.827;chr6_79011150_T_A|0.00193|0.827;chr6_79012922_A_G|0.00184|0.827;chr6_79014038_T_A|0.031|0.996;chr6_79014712_G_A|0.00193|0.827;chr6_79019772_A_C|0.00146|0.808;chr6_79019931_A_G|0.00146|0.808;chr6_79024652_A_C|0.00159|0.808;chr6_79025009_C_T|0.00159|0.808;chr6_79027389_A_G|0.00159|0.808;chr6_79029293_G_A|0.00212|0.827;chr6_79032241_A_G|0.00211|0.827;chr6_79032384_C_T|0.00211|0.827;chr6_79033230_G_A|0.0337|0.996;chr6_79034018_G_T|0.00211|0.827;chr6_79035151_C_A|0.0336|0.996;chr6_79043075_T_C|0.00159|0.808;chr6_79043356_G_C|0.00163|0.808;chr6_79043677_T_C|0.00159|0.808;chr6_79047721_A_C|0.0292|0.996;chr6_79048501_C_A|0.0016|0.808;chr6_79048506_T_G|0.0016|0.808;chr6_79051280_C_T|0.0016|0.808;chr6_79052455_G_A|0.00156|0.826;chr6_79059339_A_T|0.00156|0.808;chr6_79066387_A_G|0.00153|0.808;chr6_79073157_T_C|0.00144|0.808;chr6_79075890_C_T|0.0342|0.995;chr6_79079756_T_G|0.0213|0.963;chr6_79081265_A_G|0.0251|0.973;chr6_79081325_A_G|0.0228|0.973;chr6_79085141_A_G|0.0222|0.971;chr6_79086275_G_A|0.0295|0.984;chr6_79091101_A_G|0.00784|0.848	6.85	mathematical ability|0.996;alcohol drinking|0.982;diastolic blood pressure|0.982;cognitive function measurement|0.982;cardiovascular disease|0.894;systolic blood pressure|0.827	mathematical ability|0.996;alcohol drinking|0.982;cognitive function measurement|0.982;diastolic blood pressure|0.982;cardiovascular disease|0.894;systolic blood pressure|0.827;macula measurement|0.756;intelligence|0.669;self reported educational attainment|0.285;low density lipoprotein cholesterol measurement|0.191;response to diuretic|0.191	NA
chr11_100739815_T_C	true	11	3.04e-12	11.5	0.0674	1.018022991215786	0.741	ARHGAP42	NA	chr11_100701679_A_G|0.0215|0.883;chr11_100702389_G_A|0.0221|0.904;chr11_100710589_G_A|0.147|0.94;chr11_100739815_T_C|0.302|1;chr11_100753807_T_G|0.149|0.911;chr11_100767524_G_A|0.155|0.91;chr11_100772406_G_A|0.162|0.852	5.81	hypertension|1;alcohol consumption measurement|1;mean arterial pressure|1;cardiovascular disease|1;Agents acting on the renin-angiotensin system use measurement|1;Beta blocking agent use measurement|1;coronary artery disease|1;diastolic blood pressure|1;alcohol drinking|1;systolic blood pressure|1;reticulocyte count|0.91;heel bone mineral density|0.883;pulse pressure measurement|0.852	hypertension|1;Beta blocking agent use measurement|1;systolic blood pressure|1;Agents acting on the renin-angiotensin system use measurement|1;diastolic blood pressure|1;mean arterial pressure|1;cardiovascular disease|1;alcohol drinking|1;alcohol consumption measurement|1;coronary artery disease|1;reticulocyte count|0.91;heel bone mineral density|0.883;pulse pressure measurement|0.852;hair colour measurement|0.342;myeloid white cell count|0.162;metastasis measurement|0.121;metastatic colorectal cancer|0.121;disease progression measurement|0.121	NA
chr10_18151515_G_A	true	10	5.25e-12	11.3	0.0598	1.107770540569586	0.386	CACNB2	NA	chr10_18145261_C_G|0.013|0.54;chr10_18146087_C_T|0.0136|0.539;chr10_18147586_C_T|0.00939|0.542;chr10_18149643_G_C|0.0133|0.543;chr10_18151515_G_A|0.666|1;chr10_18151804_T_C|0.0118|0.544;chr10_18153553_C_T|0.0115|0.543;chr10_18154797_T_C|0.0205|0.541;chr10_18156159_G_A|0.00592|0.538;chr10_18179660_C_T|0.0158|0.519;chr10_18181400_T_C|0.00546|0.39;chr10_18182691_G_A|0.00639|0.394;chr10_18182865_C_T|0.0165|0.519;chr10_18183914_A_G|0.00676|0.391;chr10_18184048_A_G|0.0073|0.385;chr10_18185798_T_C|0.014|0.382;chr10_18186146_A_G|0.00784|0.385;chr10_18187018_C_T|0.02|0.511;chr10_18187384_G_A|0.0084|0.381;chr10_18190165_G_C|0.0421|0.5;chr10_18190218_A_G|0.0369|0.502	3.09	diverticular disease|1;odontogenesis|0.543;Agents acting on the renin-angiotensin system use measurement|0.39	diverticular disease|1;odontogenesis|0.543;Agents acting on the renin-angiotensin system use measurement|0.39;low density lipoprotein cholesterol measurement|0.238;heel bone mineral density|0.142	NA
chr4_105990585_G_C	true	4	6.06e-12	11.2	0.0773	1.1004321735357918	0.8290000000000001	NPNT	NA	chr4_105989801_C_T|0.455|0.999;chr4_105990585_G_C|0.538|1	4.74	systolic blood pressure|1;diastolic blood pressure|1;Agents acting on the renin-angiotensin system use measurement|1;Diuretic use measurement|1	Diuretic use measurement|1;Agents acting on the renin-angiotensin system use measurement|1;systolic blood pressure|1;diastolic blood pressure|1	NA
chr17_58127436_C_T	true	17	8.210000000000002e-12	11.1	-0.18100000000000002	8.26104132	0.0268	NA	chr17_58279141_A_G|missense_variant|0.624	chr17_58060059_C_T|0.0737|0.836;chr17_58127436_C_T|0.133|1;chr17_58268002_C_T|0.00364|0.612;chr17_58279141_A_G|0.00467|0.624;chr17_58308212_C_T|0.0122|0.613;chr17_58321761_C_T|0.0266|0.294;chr17_58322474_A_G|0.0202|0.294;chr17_58323933_G_C|0.0201|0.294;chr17_58324223_A_G|0.0195|0.294;chr17_58327264_G_C|0.00471|0.316;chr17_58327492_T_C|0.0169|0.294;chr17_58327573_C_A|0.0487|0.299;chr17_58327663_G_A|0.0195|0.294;chr17_58335292_C_T|0.0144|0.447;chr17_58336763_G_A|0.0423|0.44;chr17_58336794_G_A|0.0273|0.439;chr17_58337587_G_A|0.0276|0.439;chr17_58375686_G_A|0.114|0.599;chr17_58526132_C_T|0.0312|0.612;chr17_58602149_T_C|0.0466|0.596;chr17_58666694_T_C|0.0217|0.595;chr17_58896465_G_A|0.0108|0.608;chr17_58921119_C_T|0.0104|0.609;chr17_58993786_C_T|0.0781|0.584;chr17_59070020_T_C|0.0274|0.594;chr17_59090632_G_A|0.052|0.595;chr17_59163938_G_A|0.0208|0.609;chr17_59512886_C_A|0.00807|0.548;chr17_59604124_GATTA_G|0.0121|0.537;chr17_59692129_C_T|0.00434|0.52	4.98	neutrophil count|0.624;eosinophil count|0.624;granulocyte count|0.624;leukocyte count|0.624;basophil count|0.624;myeloperoxidase measurement|0.624;myeloid white cell count|0.624;neutrophil percentage of leukocytes|0.624	eosinophil count|0.624;neutrophil percentage of leukocytes|0.624;myeloid white cell count|0.624;myeloperoxidase measurement|0.624;basophil count|0.624;neutrophil count|0.624;leukocyte count|0.624;granulocyte count|0.624;mean platelet volume|0.143;platelet count|0.143;platelet crit|0.142;self reported educational attainment|0.138;cognitive function measurement|0.104;smoking status measurement|0.104;mathematical ability|0.104	NA
chr9_133751973_C_T	false	9	1.13e-11	10.9	-0.13699999999999998	1.593923738317757	0.0474	NA	NA	chr9_133751973_C_T|8.6e-06|1	0.46	NA	NA	NA
chr17_47198420_C_T	true	17	1.24e-11	10.9	0.0672	1.23585993251254	0.23800000000000002	MYL4	NA	chr17_46890164_G_A|0.0492|0.567;chr17_46935905_T_C|0.108|0.59;chr17_46939827_G_A|0.0692|0.62;chr17_46958746_A_T|0.0587|0.62;chr17_46969002_C_A|0.058|0.62;chr17_46977741_A_G|0.0439|0.622;chr17_47019579_T_A|0.0626|0.599;chr17_47051396_T_C|0.0348|0.678;chr17_47060667_A_G|0.085|0.694;chr17_47151194_C_A|0.118|0.964;chr17_47198420_C_T|0.145|1;chr17_47203891_T_G|0.129|1	4.43	pulse pressure measurement|0.622;Agents acting on the renin-angiotensin system use measurement|0.62;systolic blood pressure|0.59;cardiovascular disease|0.59;Calcium channel blocker use measurement|0.59;left ventricular structural measurement|0.59;QRS duration|0.59;coronary artery disease|0.59;heart function measurement|0.59;aortic root size|0.59;QRS complex|0.59;QRS amplitude|0.59	pulse pressure measurement|0.622;Agents acting on the renin-angiotensin system use measurement|0.62;cardiovascular disease|0.59;systolic blood pressure|0.59;QRS duration|0.59;left ventricular structural measurement|0.59;Calcium channel blocker use measurement|0.59;QRS amplitude|0.59;coronary artery disease|0.59;QRS complex|0.59;heart function measurement|0.59;aortic root size|0.59;chronotype measurement|0.504;heel bone mineral density|0.389;hemoglobin measurement|0.279;erythrocyte count|0.279;hematocrit|0.279;cleft lip|0.252;Cleft palate|0.252;blood urea nitrogen measurement|0.201;autoimmune thyroid disease|0.107	NA
chr19_11199780_C_G	true	19	2.0699999999999997e-11	10.7	0.43	1000000	0.00445	DOCK6	NA	chr19_10877883_A_G|0.0325|0.408;chr19_11188755_G_A|0.0407|0.316;chr19_11199780_C_G|0.886|1	3.06	NA	NA	NA
chr10_18439030_C_G	true	10	2.27e-11	10.6	-0.0685	0.7324933277361322	0.221	CACNB2	NA	chr10_18439030_C_G|0.985|1	3.38	NA	Agents acting on the renin-angiotensin system use measurement|0.793;low density lipoprotein cholesterol measurement|0.666;systolic blood pressure|0.626;alcohol consumption measurement|0.626;alcohol drinking|0.626;mean arterial pressure|0.626;Diuretic use measurement|0.617;diastolic blood pressure|0.616;pulse pressure measurement|0.541;smoking status measurement|0.513;white matter microstructure measurement|0.273	NA
chr12_115118502_T_G	true	12	2.32e-11	10.6	-0.0591	0.9447867486473194	0.364	NA	NA	chr12_115114632_A_G|0.0981|0.988;chr12_115115073_G_C|0.133|0.99;chr12_115115310_C_T|0.126|0.99;chr12_115116280_A_AT|0.132|0.99;chr12_115116718_C_T|0.126|0.99;chr12_115118062_A_G|0.166|0.995;chr12_115118502_T_G|0.178|1	4.89	hypertension|0.99;systolic blood pressure|1;platelet count|1;platelet crit|1;alcohol consumption measurement|0.99;mean arterial pressure|0.99;diastolic blood pressure|0.99;alcohol drinking|0.99;Agents acting on the renin-angiotensin system use measurement|0.99;stroke|0.99;Ischemic stroke|0.99;Diuretic use measurement|0.99;smoking status measurement|0.988	hypertension|0.99;systolic blood pressure|1;platelet count|1;platelet crit|1;alcohol drinking|0.99;alcohol consumption measurement|0.99;mean arterial pressure|0.99;diastolic blood pressure|0.99;Agents acting on the renin-angiotensin system use measurement|0.99;Ischemic stroke|0.99;Diuretic use measurement|0.99;stroke|0.99;smoking status measurement|0.988	NA
chr17_49398495_C_T	true	17	3.01e-11	10.5	-0.135	2.17068448973384	0.0462	RP11-81K2.1	NA	chr17_49249496_C_T|0.108|0.952;chr17_49263595_C_T|0.0879|0.952;chr17_49279811_C_T|0.194|0.937;chr17_49319015_A_T|0.106|0.954;chr17_49358772_A_C|0.0981|0.951;chr17_49398495_C_T|0.407|1	5.42	NA	heel bone mineral density|0.11	NA
chr9_109989291_C_T	true	9	3.1899999999999995e-11	10.5	0.0609	1.0132298096521974	0.6940000000000001	PALM2-AKAP2	NA	chr9_109989291_C_T|0.966|1	4.27	NA	NA	NA
chr2_158606382_G_A	true	2	5.69e-11	10.2	-0.0811	0.9384795482305358	0.866	PKP4	NA	chr2_158502900_G_T|0.0249|0.924;chr2_158503437_T_C|0.0241|0.924;chr2_158505052_T_A|0.0242|0.924;chr2_158513491_G_A|0.0241|0.924;chr2_158537129_G_A|0.029|0.929;chr2_158538850_G_A|0.029|0.929;chr2_158541363_T_G|0.0196|0.927;chr2_158543668_C_T|0.029|0.929;chr2_158544289_A_G|0.029|0.929;chr2_158545559_G_A|0.029|0.929;chr2_158546830_C_A|0.029|0.929;chr2_158548321_G_A|0.0289|0.93;chr2_158551369_G_A|0.0285|0.93;chr2_158566610_T_G|0.0198|0.934;chr2_158566826_G_A|0.0955|0.998;chr2_158577980_G_A|0.0198|0.934;chr2_158583427_G_A|0.02|0.934;chr2_158606382_G_A|0.118|1;chr2_158609502_T_G|0.00234|0.904;chr2_158620128_G_A|0.0254|0.935;chr2_158620405_G_A|0.0254|0.935;chr2_158631273_A_C|0.00227|0.904;chr2_158632830_A_G|0.00273|0.928;chr2_158632969_C_A|0.00286|0.928;chr2_158635071_A_G|0.0022|0.903;chr2_158639756_G_A|0.022|0.935;chr2_158642428_A_T|0.00263|0.928;chr2_158645565_C_G|0.00261|0.928;chr2_158646069_G_A|0.0222|0.935;chr2_158649541_G_A|0.00258|0.928;chr2_158656176_G_A|0.0933|0.998;chr2_158656366_A_AC|0.0182|0.933;chr2_158657577_A_G|0.0175|0.933;chr2_158676047_C_T|0.0195|0.931;chr2_158678194_C_T|0.0193|0.93;chr2_158678362_C_T|0.0334|0.929;chr2_158681698_C_T|0.0124|0.886	3.62	mathematical ability|0.904	mathematical ability|0.904;self reported educational attainment|0.714;red blood cell density measurement|0.14	NA
chr5_158555748_T_G	true	5	1.1400000000000001e-10	9.94	0.0625	0.8804243412322275	0.254	NA	NA	chr5_158504825_T_C|0.00988|0.615;chr5_158510175_A_C|0.00778|0.615;chr5_158510339_G_A|0.00778|0.615;chr5_158510418_A_G|0.00778|0.615;chr5_158510514_A_G|0.00778|0.615;chr5_158511862_C_G|0.00804|0.62;chr5_158511885_G_A|0.00768|0.615;chr5_158512319_A_G|0.00768|0.615;chr5_158512394_G_A|0.00768|0.615;chr5_158512575_G_A|0.00768|0.615;chr5_158513285_A_G|0.00768|0.615;chr5_158515688_G_T|0.00905|0.633;chr5_158515966_A_C|0.00945|0.638;chr5_158516213_G_C|0.00899|0.633;chr5_158516221_C_T|0.00899|0.633;chr5_158516468_C_A|0.00901|0.633;chr5_158517607_C_A|0.0172|0.594;chr5_158518907_A_G|0.017|0.594;chr5_158546391_T_C|0.0119|0.647;chr5_158548962_G_T|0.0101|0.653;chr5_158554977_T_G|0.0731|1;chr5_158555322_C_T|0.0731|1;chr5_158555748_T_G|0.0764|1;chr5_158555771_A_G|0.0731|1;chr5_158556313_T_A|0.0731|1;chr5_158556764_A_G|0.0736|1;chr5_158557471_A_G|0.0484|0.975;chr5_158559548_C_G|0.0721|1;chr5_158560211_A_G|0.047|0.975;chr5_158560240_C_T|0.0721|1;chr5_158561236_C_T|0.0111|0.907;chr5_158563173_G_A|0.0123|0.906;chr5_158563282_T_G|0.0125|0.906;chr5_158563423_C_G|0.00864|0.884;chr5_158564018_ACC_A|0.0142|0.905;chr5_158565656_C_T|0.0124|0.906;chr5_158565686_G_A|0.0124|0.906	3.19	NA	body fat percentage|0.83;pericardial adipose tissue measurement|0.825;cardiovascular disease|0.383;BMI-adjusted waist-hip ratio|0.377;BMI-adjusted waist circumference|0.377;waist-hip ratio|0.377;myeloid white cell count|0.339;body weight|0.331;body height|0.331;type II diabetes mellitus|0.331;high density lipoprotein cholesterol measurement|0.33;reticulocyte count|0.323;triglyceride measurement|0.302;Type 2 Diabetes Mellitus|0.182;lymphocyte count|0.125	NA
chr12_89631845_G_A	true	12	1.18e-10	9.93	0.06	1.2140830720305296	0.7120000000000001	ATP2B1	NA	chr12_89569762_G_GAGA|0.0303|0.979;chr12_89571272_C_T|0.0128|0.939;chr12_89576142_A_AACTC|0.0743|0.989;chr12_89584456_C_T|0.145|0.998;chr12_89595822_G_A|0.131|0.996;chr12_89625452_C_T|0.0462|0.988;chr12_89631845_G_A|0.251|1;chr12_89640625_G_GC|0.0824|0.99;chr12_89640630_T_C|0.0824|0.99;chr12_89648365_C_G|0.0321|0.978;chr12_89677042_CAAAG_C|0.0671|0.988	4.17	mean arterial pressure|0.996;diastolic blood pressure|0.996;pulse pressure measurement|0.996;systolic blood pressure|0.996;smoking status measurement|0.939	hypertension|0.193;pulse pressure measurement|0.996;systolic blood pressure|0.996;diastolic blood pressure|0.996;mean arterial pressure|0.996;smoking status measurement|0.939;body height|0.31;calcium measurement|0.267;chronotype measurement|0.248;hip|0.243;osteoarthritis|0.243;heel bone mineral density|0.239;bone density|0.239;FEV/FEC ratio|0.234;alcohol drinking|0.234;alcohol consumption measurement|0.234;Calcium channel blocker use measurement|0.194;Diuretic use measurement|0.194;coronary artery disease|0.193;myocardial infarction|0.193;monocyte count|0.144;eosinophil count|0.144;lymphocyte count|0.116;C-reactive protein measurement|0.116;hair colour measurement|0.113	NA
chr3_27521497_C_T	true	3	1.44e-10	9.84	0.0553	0.9095911502074688	0.40399999999999997	AC137675.1	NA	chr3_27300185_T_G|0.00235|0.289;chr3_27306603_C_T|0.00243|0.289;chr3_27328712_C_T|0.00233|0.29;chr3_27508810_T_C|0.0064|0.755;chr3_27521497_C_T|0.937|1	3.43	hypertension|1;diastolic blood pressure|1;alcohol drinking|1;cardiovascular disease|1;Agents acting on the renin-angiotensin system use measurement|1;Calcium channel blocker use measurement|1;pulse pressure measurement|1;systolic blood pressure|1;alcohol consumption measurement|1;mean arterial pressure|1;body height|0.29	hypertension|1;alcohol drinking|1;pulse pressure measurement|1;systolic blood pressure|1;alcohol consumption measurement|1;Agents acting on the renin-angiotensin system use measurement|1;mean arterial pressure|1;cardiovascular disease|1;diastolic blood pressure|1;Calcium channel blocker use measurement|1;Diuretic use measurement|0.457;appendicular lean mass|0.455;uterine fibroid|0.335;leukocyte count|0.314;smoking status measurement|0.295;body height|0.29;platelet count|0.286	NA
chr19_11551207_G_A	true	19	1.6000000000000002e-10	9.79	-0.262	1.0874805976744186	0.0117	ELOF1	NA	chr19_11551207_G_A|0.991|1	4.69	NA	NA	NA
chr16_1194631_C_T	true	16	1.76e-10	9.75	0.0578	1.2197247727272726	0.321	CACNA1H	NA	chr16_1194631_C_T|0.947|1;chr16_1194887_T_A|0.0182|0.458	3.05	NA	NA	NA
chr11_65799248_T_G	true	11	1.79e-10	9.75	-0.0551	0.8262158422649141	0.397	OVOL1	NA	chr11_65793149_C_T|0.22|0.992;chr11_65793997_C_T|0.272|0.993;chr11_65799248_T_G|0.486|1	3.95	smoking status measurement|0.993;smoking initiation|0.993;urate measurement|0.992;uric acid measurement|0.992;self reported educational attainment|0.992;mathematical ability|0.992	smoking status measurement|0.993;smoking initiation|0.993;self reported educational attainment|0.992;urate measurement|0.992;uric acid measurement|0.992;mathematical ability|0.992;Abnormality of refraction|0.564;glomerular filtration rate|0.51;creatinine measurement|0.51;reticulocyte count|0.375;triglyceride measurement|0.375;high density lipoprotein cholesterol measurement|0.375;systolic blood pressure|0.375;alcohol drinking|0.375;diastolic blood pressure|0.375;heel bone mineral density|0.375;C-reactive protein measurement|0.371;BMI-adjusted waist circumference|0.363;alcohol consumption measurement|0.265;mean arterial pressure|0.265;metabolic syndrome|0.265;Agents acting on the renin-angiotensin system use measurement|0.265;pulse pressure measurement|0.265;hair color|0.212;psoriasis|0.191;eosinophil count|0.189;acne|0.184;Myopia|0.184;refractive error measurement|0.184;age at onset|0.184;mean platelet volume|0.178;waist-hip ratio|0.136;BMI-adjusted waist-hip ratio|0.136;coronary artery disease|0.134;PR interval|0.134;red blood cell distribution width|0.133;respiratory system disease|0.131;childhood onset asthma|0.131;asthma|0.131;atopic march|0.131;allergic rhinitis|0.131;atopic eczema|0.131;allergy|0.131;Eczema|0.131;low density lipoprotein cholesterol measurement|0.11;body mass index|0.109	NA
chr2_163587293_A_G	false	2	2.47e-10	9.61	-0.0725	0.9356157899204244	0.8370000000000001	NA	NA	chr2_163587293_A_G|0.0016|1	0.8740000000000001	NA	mean arterial pressure|0.743;body height|0.605;self reported educational attainment|0.219;mathematical ability|0.217;cognitive function measurement|0.216;PR interval|0.213;polycystic ovary syndrome|0.213	NA
chr12_12724992_C_A	true	12	2.9399999999999997e-10	9.53	0.0537	1.1155942842778797	0.465	CDKN1B	NA	chr12_12724992_C_A|0.466|1;chr12_12729574_C_A|0.204|0.982;chr12_12730636_A_G|0.281|0.968	3.41	NA	waist-hip ratio|0.578;mean arterial pressure|0.578;BMI-adjusted waist-hip ratio|0.578;appendicular lean mass|0.567;lymphocyte count|0.567;myeloid white cell count|0.513;Diuretic use measurement|0.513;systolic blood pressure|0.513;mathematical ability|0.395;heel bone mineral density|0.239;platelet count|0.239;systemic lupus erythematosus|0.234;C-reactive protein measurement|0.231;body height|0.231;monocyte count|0.166;erythrocyte count|0.114	NA
chr1_6594993_G_A	true	1	3.92e-10	9.41	-0.0589	0.8164958562741846	0.281	KLHL21	NA	chr1_6584663_G_A|0.0679|0.992;chr1_6585807_G_A|0.0678|0.993;chr1_6594993_G_A|0.159|1;chr1_6599445_G_A|0.146|0.991;chr1_6600289_A_G|0.141|0.991;chr1_6601672_C_A|0.078|0.994;chr1_6602853_G_A|0.075|0.993;chr1_6602971_G_C|0.0761|0.994;chr1_6617004_A_G|0.0255|0.983;chr1_6618804_A_C|0.0258|0.983;chr1_6620847_G_A|0.0274|0.982;chr1_6635271_G_T|0.0611|0.946	3.97	heel bone mineral density|0.991;FEV/FEC ratio|0.983	heel bone mineral density|0.991;FEV/FEC ratio|0.983;systolic blood pressure|0.949;age at menopause|0.311;type II diabetes mellitus|0.175;HMG CoA reductase inhibitor use measurement|0.172	NA
chr4_184956408_T_C	true	4	4.81e-10	9.32	-0.128	0.9080556269662922	0.045	NA	NA	chr4_184956408_T_C|0.893|1;chr4_184959631_G_T|0.096|0.912	3.11	NA	NA	NA
chr1_230714652_G_A	true	1	6.63e-10	9.18	0.0826	0.9217401288191579	0.11199999999999999	AGT	NA	chr1_230713711_C_T|0.0898|1;chr1_230713736_C_T|0.0899|1;chr1_230714337_C_T|0.0869|1;chr1_230714652_G_A|0.0978|1;chr1_230714912_C_T|0.0857|1;chr1_230715194_C_A|0.0893|0.999;chr1_230715298_T_C|0.0818|0.999;chr1_230715449_G_C|0.08|0.999;chr1_230715681_C_A|0.0856|0.998;chr1_230730217_G_A|0.0123|0.639;chr1_230732906_T_C|0.0141|0.633;chr1_230737742_G_T|0.0611|0.453;chr1_230742815_G_A|0.0419|0.45;chr1_230743765_T_C|0.04|0.45	4.02	blood protein measurement|1;angiotensinogen measurement|0.45	blood protein measurement|1;angiotensinogen measurement|0.45;Agents acting on the renin-angiotensin system use measurement|0.145;cardiovascular disease|0.145;Beta blocking agent use measurement|0.145;diastolic blood pressure|0.145;systolic blood pressure|0.145;mean arterial pressure|0.144;coronary artery disease|0.144	NA
chr13_29545363_C_T	true	13	6.700000000000001e-10	9.17	-0.0544	0.8557582875259114	0.643	SLC7A1	NA	chr13_29545363_C_T|0.392|1;chr13_29563691_T_C|0.185|0.984;chr13_29571533_CG_C|0.156|0.984;chr13_29572064_C_T|0.157|0.984;chr13_29580212_G_C|0.0938|0.975	3.81	systolic blood pressure|0.984	systolic blood pressure|0.984;Diuretic use measurement|0.323	NA
chr1_25022459_G_GT	true	1	7.47e-10	9.13	0.0536	0.9905442427140936	0.613	MIR4425	NA	chr1_25022459_G_GT|0.798|1;chr1_25025090_G_A|0.156|0.915	2.47	NA	Alopecia|0.253;cardiovascular disease|0.199;balding measurement|0.146;androgenetic alopecia|0.136	NA
chr6_43378065_C_T	true	6	9.18e-10	9.04	0.0566	0.9396351226386808	0.294	NA	NA	chr6_43292273_A_AC|0.0923|0.856;chr6_43292922_T_C|0.0632|0.911;chr6_43294966_A_T|0.0683|0.917;chr6_43311983_G_A|0.0689|0.917;chr6_43325892_T_C|0.0649|0.917;chr6_43331320_T_G|0.0518|0.926;chr6_43336269_C_A|0.0512|0.927;chr6_43340625_C_T|0.0495|0.927;chr6_43364909_TAA_T|0.0563|0.927;chr6_43378065_C_T|0.152|1;chr6_43380774_A_G|0.0305|0.956;chr6_43381477_G_A|0.0305|0.956;chr6_43381570_A_C|0.0306|0.956;chr6_43382057_G_A|0.0307|0.956;chr6_43385242_A_G|0.0668|0.952;chr6_43386693_A_G|0.0641|0.952	3.9	systolic blood pressure|0.956;alcohol drinking|0.952;Systolic Blood Pressure|0.927;pulse pressure measurement|0.927;mean arterial pressure|0.927;urate measurement|0.917;diastolic blood pressure|0.917;stroke|0.917	systolic blood pressure|0.956;alcohol drinking|0.952;pulse pressure measurement|0.927;Systolic Blood Pressure|0.927;mean arterial pressure|0.927;stroke|0.917;diastolic blood pressure|0.917;urate measurement|0.917;smoking status measurement|0.831;waist-hip ratio|0.706;Calcium channel blocker use measurement|0.706;Diuretic use measurement|0.684;Agents acting on the renin-angiotensin system use measurement|0.684;platelet count|0.681;chronotype measurement|0.681;platelet crit|0.681;mean corpuscular hemoglobin concentration|0.681;mean corpuscular volume|0.681;heel bone mineral density|0.68;age at menarche|0.257;hemoglobin measurement|0.109	NA
chr13_21735437_A_G	true	13	9.379999999999999e-10	9.03	0.053	0.9110394362151508	0.611	NA	NA	chr13_21724784_G_A|0.0471|0.867;chr13_21731630_T_G|0.104|1;chr13_21735437_A_G|0.114|1;chr13_21737964_T_G|0.114|1;chr13_21738514_G_A|0.105|0.999;chr13_21740007_T_C|0.0348|0.972;chr13_21743784_T_G|0.0556|0.873;chr13_21744175_C_A|0.0361|0.974;chr13_21744192_G_T|0.0584|0.872;chr13_21744213_C_T|0.058|0.872;chr13_21744303_A_G|0.0584|0.872;chr13_21744358_C_T|0.0591|0.872;chr13_21744367_G_C|0.0591|0.872;chr13_21744572_A_C|0.0492|0.87	3.85	Diuretic use measurement|0.972;systolic blood pressure|0.972;pulse pressure measurement|0.972;Agents acting on the renin-angiotensin system use measurement|0.972;cardiovascular disease|0.972	pulse pressure measurement|0.972;systolic blood pressure|0.972;Agents acting on the renin-angiotensin system use measurement|0.972;Diuretic use measurement|0.972;cardiovascular disease|0.972;dehydroepiandrosterone sulphate measurement|0.788	NA
chr2_164106976_T_C	true	2	9.919999999999999e-10	9	0.053	1.1103508702499143	0.614	AC092684.1	NA	chr2_164106976_T_C|0.589|1;chr2_164143373_A_C|0.0632|0.788;chr2_164151656_C_G|0.283|0.98;chr2_164155317_C_A|0.0107|0.89;chr2_164157783_C_T|0.00348|0.848;chr2_164193174_C_T|0.00334|0.807	2.83	systolic blood pressure|1;mean arterial pressure|1;smoking status measurement|1;diastolic blood pressure|1	hypertension|0.724;systolic blood pressure|1;smoking status measurement|1;diastolic blood pressure|1;mean arterial pressure|1;pulse pressure measurement|0.815;alcohol drinking|0.815;alcohol consumption measurement|0.632;Agents acting on the renin-angiotensin system use measurement|0.417;Diuretic use measurement|0.417;Calcium channel blocker use measurement|0.221;mathematical ability|0.19;cognitive function measurement|0.19;coronary artery disease|0.186	NA
chr4_110465271_G_A	true	4	1.23e-9	8.91	-0.0649	0.9530942181818184	0.807	ENPEP	NA	chr4_110412445_G_T|0.012|0.813;chr4_110416684_A_G|0.0148|0.815;chr4_110417731_C_G|0.0149|0.815;chr4_110419189_T_C|0.0149|0.815;chr4_110420478_G_C|0.0149|0.815;chr4_110421376_A_AATTTATAG|0.0152|0.815;chr4_110422107_C_A|0.0272|0.995;chr4_110422537_G_A|0.0149|0.815;chr4_110422785_A_G|0.0149|0.815;chr4_110430540_C_G|0.0149|0.815;chr4_110433068_C_G|0.0135|0.815;chr4_110434223_G_C|0.0267|0.994;chr4_110434534_A_C|0.0282|0.995;chr4_110437532_C_G|0.015|0.815;chr4_110438354_G_A|0.015|0.815;chr4_110439533_C_T|0.0281|0.995;chr4_110442743_A_T|0.015|0.815;chr4_110443011_T_C|0.0182|0.812;chr4_110443162_T_C|0.0166|0.815;chr4_110445559_G_A|0.033|0.995;chr4_110448132_T_C|0.0325|0.995;chr4_110448410_T_G|0.0152|0.816;chr4_110449945_G_T|0.0152|0.816;chr4_110450039_C_T|0.0152|0.816;chr4_110451922_A_C|0.0307|0.82;chr4_110453119_G_A|0.0556|1;chr4_110457206_G_A|0.0309|0.82;chr4_110458430_C_CAAG|0.0309|0.82;chr4_110458563_A_G|0.0311|0.82;chr4_110459603_G_A|0.0605|1;chr4_110465042_T_C|0.0629|1;chr4_110465271_G_A|0.0648|1;chr4_110466650_T_C|0.0367|0.82;chr4_110466905_G_C|0.0369|0.82;chr4_110467109_T_C|0.0382|0.82;chr4_110469983_A_G|0.0331|0.996	4.35	pulse pressure measurement|1;systolic blood pressure|0.995;diastolic blood pressure|0.995;mean arterial pressure|0.995	hypertension|0.773;pulse pressure measurement|1;diastolic blood pressure|0.995;mean arterial pressure|0.995;systolic blood pressure|0.995;Calcium channel blocker use measurement|0.89;cardiovascular disease|0.89;metabolite measurement|0.886;atrial fibrillation|0.122	NA
chr4_153561638_G_C	true	4	1.36e-9	8.87	0.545	3.1251508475	0.00234	KIAA0922	NA	chr4_153561638_G_C|0.998|1	2.54	NA	NA	NA
chr12_18022971_G_A	true	12	2.14e-9	8.67	-0.158	45.00421268571429	0.0272	NA	NA	chr12_18022570_C_T|0.478|1;chr12_18022971_G_A|0.48|1	3.1	NA	NA	NA
chr10_61751548_G_A	true	10	2.46e-9	8.61	-0.0833	0.6743047595959596	0.102	C10orf107	NA	chr10_61664453_G_GA|0.0192|0.943;chr10_61673732_G_A|0.0238|0.942;chr10_61684459_C_A|0.0219|0.944;chr10_61684670_G_A|0.0219|0.944;chr10_61690870_G_A|0.0309|0.946;chr10_61695839_A_G|0.0268|0.945;chr10_61700896_T_C|0.0351|0.947;chr10_61702607_G_A|0.0368|0.947;chr10_61710150_A_G|0.034|0.949;chr10_61712876_G_C|0.0331|0.951;chr10_61714751_G_T|0.0364|0.953;chr10_61716343_A_G|0.0398|0.954;chr10_61722407_C_A|0.0405|0.954;chr10_61724831_A_C|0.0405|0.954;chr10_61727211_T_C|0.0406|0.954;chr10_61732417_A_G|0.0387|0.955;chr10_61740193_T_C|0.0364|0.955;chr10_61751548_G_A|0.0903|1;chr10_61755923_T_G|0.0882|1;chr10_61758620_C_T|0.0738|0.999;chr10_61758990_G_A|0.085|1;chr10_61792015_G_A|0.0283|0.981;chr10_61792840_C_T|0.0349|0.974	3.59	systolic blood pressure|1;cardiovascular disease|1;Agents acting on the renin-angiotensin system use measurement|1;Diuretic use measurement|0.999;alcohol drinking|0.954;mean arterial pressure|0.954;Calcium channel blocker use measurement|0.944	hypertension|0.403;systolic blood pressure|1;cardiovascular disease|1;Agents acting on the renin-angiotensin system use measurement|1;Diuretic use measurement|0.999;mean arterial pressure|0.954;alcohol drinking|0.954;Calcium channel blocker use measurement|0.944;diastolic blood pressure|0.785;smoking status measurement|0.785;Beta blocking agent use measurement|0.402	NA
chr9_133657152_C_T	true	9	2.7e-9	8.57	-0.10099999999999999	0.9267562405161288	0.0669	DBH	chr9_133657152_C_T|missense_variant|1	chr9_133657152_C_T|0.945|1;chr9_133670555_G_A|0.0553|0.863	4.25	systolic blood pressure|1;diastolic blood pressure|1;Calcium channel blocker use measurement|1;cardiovascular disease|1	Calcium channel blocker use measurement|1;cardiovascular disease|1;systolic blood pressure|1;diastolic blood pressure|1;blood protein measurement|0.105	NA
chr19_17086202_A_G	true	19	2.9100000000000005e-9	8.54	0.061	0.7566694825581397	0.213	MYO9B	NA	chr19_17043995_G_A|0.0136|0.821;chr19_17045691_T_C|0.0381|0.873;chr19_17048969_A_C|0.0361|0.873;chr19_17050780_C_T|0.0361|0.873;chr19_17056171_G_A|0.0397|0.948;chr19_17057341_C_T|0.0357|0.948;chr19_17058271_G_A|0.0325|0.951;chr19_17065947_C_G|0.039|0.948;chr19_17069548_C_A|0.0404|0.949;chr19_17078976_G_A|0.105|0.998;chr19_17085566_G_A|0.119|0.999;chr19_17086202_A_G|0.162|1;chr19_17088504_T_C|0.0208|0.912;chr19_17093517_A_G|0.0201|0.911;chr19_17101372_G_T|0.0124|0.906;chr19_17103263_C_T|0.0237|0.91;chr19_17104392_G_A|0.0126|0.906;chr19_17108295_G_A|0.14|0.784;chr19_17116525_C_T|0.0107|0.886;chr19_17117744_C_T|0.0145|0.861	3.19	mean arterial pressure|0.998;BMI-adjusted waist circumference|0.911;BMI-adjusted waist-hip ratio|0.911;prostate carcinoma|0.91;Agents acting on the renin-angiotensin system use measurement|0.784;waist-hip ratio|0.784;cardiovascular disease|0.784;systolic blood pressure|0.784;reticulocyte count|0.784	mean arterial pressure|0.998;BMI-adjusted waist-hip ratio|0.911;BMI-adjusted waist circumference|0.911;prostate carcinoma|0.91;systolic blood pressure|0.91;waist-hip ratio|0.784;cardiovascular disease|0.784;Agents acting on the renin-angiotensin system use measurement|0.784;reticulocyte count|0.784;asthma|0.342	NA
chr6_126851397_A_G	true	6	3.77e-9	8.42	0.0499	1.1466389399624768	0.483	NA	NA	chr6_126782640_C_A|0.00413|0.927;chr6_126783942_G_A|0.00413|0.927;chr6_126783943_A_T|0.00413|0.927;chr6_126784347_A_G|0.00572|0.915;chr6_126786034_G_A|0.00416|0.927;chr6_126786083_T_C|0.00416|0.927;chr6_126786511_A_G|0.00413|0.927;chr6_126787775_A_G|0.00419|0.927;chr6_126794309_C_T|0.00536|0.929;chr6_126795330_G_A|0.00531|0.929;chr6_126795494_GTTC_G|0.00531|0.929;chr6_126795642_T_G|0.00531|0.929;chr6_126796038_T_C|0.00531|0.929;chr6_126796579_G_A|0.00531|0.929;chr6_126797927_C_T|0.00485|0.929;chr6_126802106_GT_G|0.00507|0.922;chr6_126805001_T_C|0.00483|0.931;chr6_126813930_A_G|0.0125|0.935;chr6_126813987_T_C|0.0115|0.935;chr6_126814916_A_G|0.0113|0.936;chr6_126821313_C_T|0.0145|0.928;chr6_126826559_C_T|0.00413|0.952;chr6_126834336_G_A|0.00597|0.96;chr6_126834566_C_T|0.00591|0.96;chr6_126836897_C_T|0.00586|0.96;chr6_126837978_G_A|0.00586|0.96;chr6_126838165_C_A|0.00586|0.96;chr6_126838837_G_A|0.00586|0.96;chr6_126839119_G_T|0.00586|0.96;chr6_126839921_A_G|0.00586|0.96;chr6_126840072_A_C|0.00586|0.96;chr6_126840716_C_T|0.00586|0.96;chr6_126840925_A_T|0.00586|0.96;chr6_126841261_A_G|0.00586|0.96;chr6_126841981_C_T|0.00586|0.96;chr6_126841991_A_G|0.00586|0.96;chr6_126842313_G_T|0.00611|0.96;chr6_126842591_ACT_A|0.00569|0.96;chr6_126842772_CTTTTA_C|0.00586|0.96;chr6_126843215_A_G|0.00586|0.96;chr6_126843297_T_C|0.00586|0.96;chr6_126844145_C_T|0.00586|0.96;chr6_126844330_C_T|0.00586|0.96;chr6_126844511_A_G|0.00586|0.96;chr6_126844700_G_A|0.00586|0.96;chr6_126844797_C_A|0.00586|0.96;chr6_126845261_G_A|0.00586|0.96;chr6_126845309_T_C|0.00586|0.96;chr6_126845743_A_C|0.00537|0.96;chr6_126846207_T_C|0.00586|0.96;chr6_126846251_A_G|0.00586|0.96;chr6_126846367_A_G|0.00586|0.96;chr6_126846531_CA_C|0.00586|0.96;chr6_126846570_T_C|0.00586|0.96;chr6_126846774_T_A|0.00586|0.96;chr6_126846899_A_T|0.00526|0.949;chr6_126847007_A_C|0.00586|0.96;chr6_126847230_A_G|0.00586|0.96;chr6_126847303_C_T|0.00586|0.96;chr6_126847765_T_A|0.00586|0.96;chr6_126848210_G_T|0.00586|0.96;chr6_126848277_T_C|0.00586|0.96;chr6_126848897_A_G|0.00586|0.96;chr6_126849461_T_C|0.0069|0.961;chr6_126849592_C_T|0.0069|0.961;chr6_126849599_A_G|0.0069|0.961;chr6_126849723_T_C|0.0069|0.961;chr6_126849906_T_C|0.0069|0.961;chr6_126849963_GC_G|0.0069|0.961;chr6_126850042_C_T|0.00701|0.959;chr6_126850161_T_C|0.00646|0.961;chr6_126850188_C_T|0.0069|0.961;chr6_126850309_C_T|0.0069|0.961;chr6_126850502_A_G|0.0069|0.961;chr6_126850649_C_T|0.0069|0.961;chr6_126850702_C_T|0.00699|0.961;chr6_126851397_A_G|0.0149|1;chr6_126851737_T_C|0.00724|0.961;chr6_126851880_A_G|0.00716|0.961;chr6_126851885_G_A|0.0069|0.961;chr6_126852029_G_A|0.00691|0.961;chr6_126852077_A_G|0.0069|0.961;chr6_126852122_C_G|0.0069|0.961;chr6_126852631_G_A|0.00689|0.961;chr6_126853045_C_A|0.00701|0.961;chr6_126853157_G_A|0.00689|0.961;chr6_126853230_C_G|0.00626|0.961;chr6_126853231_A_G|0.00598|0.96;chr6_126853864_T_C|0.00689|0.961;chr6_126854800_G_A|0.00586|0.96;chr6_126855017_A_G|0.00586|0.96;chr6_126855089_TGTAAA_T|0.00586|0.96;chr6_126855835_C_A|0.00586|0.96;chr6_126855874_T_C|0.00586|0.96;chr6_126856325_A_G|0.00586|0.96;chr6_126856330_T_C|0.00586|0.96;chr6_126856505_G_T|0.00565|0.96;chr6_126856574_T_C|0.00603|0.959;chr6_126856813_A_G|0.00586|0.96;chr6_126856980_T_C|0.00586|0.96;chr6_126857581_G_A|0.00586|0.96;chr6_126858586_T_TATCTC|0.00586|0.96;chr6_126858875_A_T|0.00586|0.96;chr6_126859944_T_C|0.00586|0.96;chr6_126860093_G_A|0.00586|0.96;chr6_126861666_C_A|0.00586|0.96;chr6_126861670_G_C|0.00586|0.96;chr6_126861675_C_A|0.00586|0.96;chr6_126861882_T_G|0.00586|0.96;chr6_126861967_C_T|0.00586|0.96;chr6_126861976_C_T|0.00586|0.96;chr6_126862785_G_C|0.00998|0.94;chr6_126862899_T_A|0.00998|0.94;chr6_126863321_A_T|0.0104|0.94;chr6_126863529_T_G|0.00998|0.94;chr6_126863692_A_G|0.00985|0.94;chr6_126863841_G_A|0.0096|0.939;chr6_126863842_A_T|0.00926|0.939;chr6_126863951_C_T|0.00999|0.94;chr6_126863987_CT_C|0.00985|0.94;chr6_126864306_T_C|0.00998|0.94;chr6_126864344_G_A|0.00838|0.937;chr6_126864363_T_C|0.00998|0.94;chr6_126864508_T_C|0.00998|0.94;chr6_126864791_G_GT|0.0099|0.94;chr6_126865874_T_C|0.00864|0.939;chr6_126866102_C_CA|0.0102|0.939;chr6_126866717_T_G|0.00887|0.939;chr6_126866804_C_G|0.00948|0.94;chr6_126867103_G_A|0.00586|0.96;chr6_126867357_C_T|0.00586|0.96;chr6_126867358_C_A|0.00586|0.96;chr6_126868163_G_C|0.00586|0.96;chr6_126868882_G_A|0.00551|0.96;chr6_126872992_A_G|0.00546|0.96;chr6_126873028_C_T|0.00546|0.96;chr6_126876628_A_G|0.00546|0.96;chr6_126877181_TA_T|0.00716|0.959;chr6_126877485_A_G|0.00715|0.959;chr6_126879498_A_G|0.00714|0.959;chr6_126882720_G_A|0.00712|0.959;chr6_126884350_G_C|0.00713|0.959;chr6_126884390_AAAACAGATAC_A|0.00653|0.958	4.36	hypertension|0.959;alcohol drinking|0.96;systolic blood pressure|0.96;Beta blocking agent use measurement|0.96;cardiovascular disease|0.96;Agents acting on the renin-angiotensin system use measurement|0.96;mean arterial pressure|0.959;diastolic blood pressure|0.959;Diuretic use measurement|0.952;triglyceride measurement|0.939	hypertension|0.959;systolic blood pressure|0.96;Agents acting on the renin-angiotensin system use measurement|0.96;Beta blocking agent use measurement|0.96;alcohol drinking|0.96;cardiovascular disease|0.96;mean arterial pressure|0.959;diastolic blood pressure|0.959;Diuretic use measurement|0.952;triglyceride measurement|0.939;waist-hip ratio|0.402;BMI-adjusted waist circumference|0.402;BMI-adjusted waist-hip ratio|0.402;optic disc size measurement|0.31;heel bone mineral density|0.267;cortical surface area measurement|0.267;total cortical area measurement|0.267;self reported educational attainment|0.267;appendicular lean mass|0.213;brain volume measurement|0.196;occipital lobe volume measurement|0.195;sex interaction measurement|0.163;age at assessment|0.163;type II diabetes mellitus|0.105;sclerosing cholangitis|0.105;intracranial volume measurement|0.104	NA
chr20_10955381_T_G	true	20	3.829999999999999e-9	8.42	0.0572	1.0881903703118831	0.256	RP11-103J8.1	NA	chr20_10955381_T_G|0.333|1;chr20_10956332_G_A|0.313|0.93;chr20_10961201_A_G|0.0167|0.866;chr20_10962096_C_A|0.0206|0.864;chr20_10968177_G_GA|0.00608|0.795;chr20_10969935_T_C|0.00608|0.795;chr20_10970264_TAAAG_T|0.00635|0.795;chr20_10970582_AAGGAGC_A|0.00635|0.795;chr20_10971010_T_C|0.00636|0.795;chr20_10975847_C_T|0.00804|0.794;chr20_10978014_T_C|0.00862|0.79;chr20_10978298_C_G|0.00869|0.79;chr20_10981287_C_A|0.00938|0.79;chr20_10983718_T_C|0.00807|0.399;chr20_10985686_C_T|0.0183|0.726;chr20_10986514_G_A|0.0189|0.726;chr20_10988243_C_T|0.0179|0.726;chr20_10990938_TC_T|0.0169|0.725;chr20_10991096_T_C|0.0191|0.726;chr20_10991762_T_TA|0.0189|0.726;chr20_10992610_G_T|0.0197|0.726;chr20_10994314_T_C|0.0219|0.726;chr20_10994562_A_T|0.0217|0.726;chr20_10996983_A_G|0.0212|0.724	2.56	bladder carcinoma|0.79;parental longevity|0.399	hypertension|0.24;bladder carcinoma|0.79;heel bone mineral density|0.568;parental longevity|0.399;alcohol drinking|0.338;diastolic blood pressure|0.338;systolic blood pressure|0.241;Agents acting on the renin-angiotensin system use measurement|0.241;alcohol consumption measurement|0.241;cardiovascular disease|0.241;mean arterial pressure|0.241;smoking status measurement|0.24;Beta blocking agent use measurement|0.24;Diuretic use measurement|0.24;waist-hip ratio|0.147;BMI-adjusted waist circumference|0.138	NA
chr4_105984452_A_G	false	4	3.87e-9	8.41	-0.0844	0.7739864896551725	0.0968	NPNT	NA	chr4_105984452_A_G|1.26e-05|1	0.381	NA	NA	NA
chr2_218856229_TAGG_T	true	2	4.7499999999999995e-9	8.32	0.0903	1.5664872843910804	0.084	WNT6	NA	chr2_218835276_G_A|0.186|0.921;chr2_218856229_TAGG_T|0.752|1;chr2_218994449_G_A|0.0608|0.911	2.79	high density lipoprotein cholesterol measurement|0.921;triglyceride measurement|0.921;cardiovascular disease|0.921;heel bone mineral density|0.921;apolipoprotein A 1 measurement|0.921;waist-hip ratio|0.921;lymphocyte count|0.921;type II diabetes mellitus|0.911;Type 2 Diabetes Mellitus|0.911	high density lipoprotein cholesterol measurement|0.921;cardiovascular disease|0.921;heel bone mineral density|0.921;apolipoprotein A 1 measurement|0.921;waist-hip ratio|0.921;triglyceride measurement|0.921;lymphocyte count|0.921;type II diabetes mellitus|0.911;Type 2 Diabetes Mellitus|0.911	NA
chr20_64072137_C_T	true	20	4.85e-9	8.31	0.0566	1.0437726541858	0.259	TCEA2	NA	chr20_64062966_G_T|0.0894|0.975;chr20_64064281_T_A|0.0297|0.953;chr20_64067491_GCTGGA_G|0.149|0.97;chr20_64072137_C_T|0.587|1;chr20_64093345_C_T|0.115|0.382	2.6	NA	low density lipoprotein cholesterol measurement|0.38;pulse pressure measurement|0.38;anxiety measurement|0.38;systolic blood pressure|0.38;glomerular filtration rate|0.364;metabolic syndrome|0.357;mathematical ability|0.348;triglyceride measurement|0.347	NA
chr11_10293917_T_TCCCCGACGCCCGG	true	11	5.2900000000000006e-9	8.28	0.0648	2.171410979310345	0.182	SBF2	NA	chr11_9923789_C_T|0.00412|0.604;chr11_9975348_T_C|0.0071|0.602;chr11_10038937_G_A|0.00442|0.616;chr11_10046345_C_T|0.00691|0.829;chr11_10057252_G_A|0.00735|0.837;chr11_10057993_GA_G|0.0069|0.837;chr11_10076642_G_A|0.00699|0.833;chr11_10077602_G_A|0.00699|0.833;chr11_10086782_A_T|0.00618|0.833;chr11_10105884_G_C|0.0066|0.832;chr11_10106497_C_T|0.00466|0.829;chr11_10124487_T_G|0.00984|0.85;chr11_10124966_G_A|0.0181|0.849;chr11_10133627_C_G|0.0134|0.768;chr11_10135578_A_G|0.00994|0.85;chr11_10135905_C_T|0.00994|0.85;chr11_10136229_A_G|0.00317|0.614;chr11_10137251_C_T|0.0098|0.85;chr11_10137767_G_A|0.00984|0.85;chr11_10139895_G_A|0.0098|0.85;chr11_10141815_C_A|0.0098|0.85;chr11_10142177_C_A|0.0098|0.85;chr11_10142788_G_A|0.00841|0.849;chr11_10144538_C_T|0.00994|0.85;chr11_10145959_G_C|0.0098|0.85;chr11_10150021_T_C|0.00396|0.829;chr11_10150105_T_C|0.00396|0.829;chr11_10154155_TC_T|0.00577|0.835;chr11_10159090_A_G|0.00479|0.835;chr11_10159376_G_C|0.00611|0.84;chr11_10164293_T_A|0.00436|0.841;chr11_10164675_A_G|0.00439|0.841;chr11_10164742_G_A|0.00796|0.616;chr11_10166445_G_A|0.00518|0.841;chr11_10167844_C_T|0.00519|0.841;chr11_10171087_A_G|0.00504|0.841;chr11_10171262_T_A|0.00737|0.616;chr11_10171445_G_A|0.00761|0.616;chr11_10171974_C_T|0.00758|0.616;chr11_10172741_AC_A|0.00521|0.841;chr11_10174327_G_T|0.00864|0.62;chr11_10175077_T_A|0.00522|0.841;chr11_10177428_T_G|0.00508|0.842;chr11_10183799_G_A|0.00722|0.818;chr11_10183849_G_A|0.00722|0.818;chr11_10185130_G_A|0.00722|0.818;chr11_10185871_A_C|0.00695|0.818;chr11_10186234_A_G|0.00509|0.842;chr11_10190354_T_A|0.00753|0.617;chr11_10190632_T_C|0.00658|0.839;chr11_10194249_A_T|0.00647|0.856;chr11_10194603_C_T|0.0051|0.855;chr11_10202810_T_C|0.00524|0.856;chr11_10204027_T_C|0.0046|0.848;chr11_10204301_A_C|0.00591|0.854;chr11_10206806_A_G|0.00422|0.85;chr11_10206899_A_G|0.00487|0.849;chr11_10208939_T_C|0.00379|0.848;chr11_10209257_A_G|0.00549|0.846;chr11_10211166_A_G|0.00522|0.856;chr11_10211466_A_G|0.00519|0.856;chr11_10212183_A_G|0.00515|0.856;chr11_10213165_G_T|0.00482|0.856;chr11_10217318_G_T|0.00366|0.856;chr11_10219144_C_T|0.00461|0.856;chr11_10220798_C_T|0.00453|0.848;chr11_10226789_T_C|0.00455|0.856;chr11_10229111_T_G|0.00454|0.856;chr11_10229830_C_T|0.00454|0.856;chr11_10230199_T_C|0.00455|0.856;chr11_10230294_C_A|0.00869|0.629;chr11_10231875_C_T|0.00454|0.856;chr11_10233143_A_G|0.0045|0.856;chr11_10233668_A_G|0.00372|0.854;chr11_10234248_T_C|0.0044|0.856;chr11_10236208_T_C|0.00412|0.856;chr11_10240125_C_T|0.00409|0.856;chr11_10242663_A_G|0.00725|0.631;chr11_10243953_C_T|0.00781|0.629;chr11_10244675_A_G|0.00808|0.629;chr11_10245223_A_G|0.00781|0.629;chr11_10245336_AG_A|0.00781|0.629;chr11_10245365_C_T|0.00781|0.629;chr11_10245772_A_C|0.00408|0.856;chr11_10245803_G_C|0.00399|0.857;chr11_10247046_C_T|0.00715|0.629;chr11_10247137_C_A|0.00715|0.629;chr11_10247267_C_T|0.00723|0.629;chr11_10247631_A_G|0.00781|0.629;chr11_10247736_G_A|0.00781|0.629;chr11_10249074_T_C|0.00781|0.629;chr11_10249550_T_A|0.00781|0.629;chr11_10250042_T_C|0.00805|0.629;chr11_10250254_G_T|0.00322|0.867;chr11_10251005_C_T|0.00753|0.635;chr11_10251581_C_T|0.00756|0.635;chr11_10252660_A_T|0.00451|0.632;chr11_10253573_T_C|0.00654|0.635;chr11_10253627_T_C|0.00753|0.635;chr11_10253796_T_G|0.00875|0.628;chr11_10253871_C_A|0.00753|0.635;chr11_10254521_G_A|0.00781|0.629;chr11_10255351_A_T|0.00409|0.856;chr11_10256884_C_T|0.00781|0.629;chr11_10257290_A_G|0.00409|0.856;chr11_10259599_C_T|0.00402|0.866;chr11_10263857_C_T|0.0041|0.867;chr11_10266263_G_A|0.0039|0.867;chr11_10266322_G_A|0.00416|0.867;chr11_10272784_T_TAAC|0.00585|0.858;chr11_10273024_C_T|0.00425|0.867;chr11_10274947_A_T|0.00431|0.857;chr11_10275106_C_T|0.00839|0.629;chr11_10275120_C_T|0.00825|0.629;chr11_10277917_G_A|0.00425|0.867;chr11_10282498_C_T|0.00493|0.868;chr11_10286862_C_T|0.00488|0.868;chr11_10289790_T_A|0.0103|0.63;chr11_10293917_T_TCCCCGACGCCCGG|0.0349|1;chr11_10293930_TCCCCGACGCCCGG_GCCCCGACGCCCGG|0.00304|0.871;chr11_10295169_T_C|0.00632|0.863;chr11_10296596_T_C|0.00615|0.874;chr11_10297776_C_T|0.00615|0.874;chr11_10298615_G_A|0.00613|0.874;chr11_10300895_T_C|0.0061|0.874;chr11_10301397_T_A|0.00616|0.874;chr11_10302312_A_C|0.00608|0.874;chr11_10302324_C_T|0.00608|0.874;chr11_10308498_A_G|0.00339|0.838;chr11_10308902_T_TA|0.00359|0.839;chr11_10310742_G_T|0.00341|0.846;chr11_10313794_T_C|0.00427|0.845;chr11_10314054_T_G|0.00367|0.846;chr11_10314115_G_A|0.00368|0.846;chr11_10314153_T_G|0.0043|0.845;chr11_10315851_A_G|0.00442|0.845;chr11_10316093_T_C|0.0044|0.845;chr11_10316563_C_A|0.00377|0.846;chr11_10316934_G_A|0.00364|0.846;chr11_10317217_A_T|0.00361|0.846;chr11_10318939_C_T|0.00364|0.846;chr11_10323889_A_G|0.00358|0.846;chr11_10325447_T_G|0.00368|0.845;chr11_10326106_GA_G|0.00345|0.845;chr11_10326299_G_T|0.00349|0.845;chr11_10327168_T_C|0.00363|0.845;chr11_10327906_G_A|0.00359|0.845;chr11_10328991_G_A|0.00402|0.844;chr11_10329798_A_G|0.00417|0.845;chr11_10329875_TG_T|0.00321|0.845;chr11_10332461_T_C|0.00369|0.845;chr11_10333634_G_A|0.00362|0.844;chr11_10335481_A_G|0.00361|0.844;chr11_10337712_GGAGA_G|0.00301|0.844;chr11_10345522_G_T|0.0056|0.836;chr11_10345925_C_T|0.00615|0.836	2.78	hypertension|0.629;systolic blood pressure|0.844;diastolic blood pressure|0.844;pulse pressure measurement|0.844	hypertension|0.629;systolic blood pressure|0.844;diastolic blood pressure|0.844;pulse pressure measurement|0.844;erythrocyte count|0.47;hematocrit|0.464;red blood cell density measurement|0.464;hemoglobin measurement|0.453;Calcium channel blocker use measurement|0.406;vasoactive peptide measurement|0.282;birth weight|0.282;hair colour measurement|0.241;BMI-adjusted waist-hip ratio|0.235;waist-hip ratio|0.235;appendicular lean mass|0.234;cutaneous melanoma|0.224;hair color|0.224;neuroticism measurement|0.218;urinary albumin to creatinine ratio|0.218;body height|0.188;pro‐adrenomedullin measurement|0.125	NA
chr10_103939849_T_C	true	10	5.679999999999999e-9	8.25	0.11699999999999999	32.9523293625	0.0459	NA	chr10_104057158_C_T|missense_variant|0.908	chr10_103825995_C_T|0.0147|0.968;chr10_103911925_C_T|0.0553|0.986;chr10_103918153_C_A|0.0877|0.992;chr10_103920828_T_C|0.0876|0.992;chr10_103938510_T_C|0.00504|0.769;chr10_103939849_T_C|0.148|1;chr10_103939945_A_AT|0.00501|0.769;chr10_103939949_C_T|0.00501|0.769;chr10_103939950_AGC_A|0.00501|0.769;chr10_103939952_C_CATT|0.00501|0.769;chr10_103942063_C_T|0.00643|0.767;chr10_103942226_A_C|0.00496|0.768;chr10_103942268_T_C|0.00507|0.769;chr10_103943166_A_C|0.00507|0.769;chr10_103943326_T_C|0.00507|0.769;chr10_103946033_T_C|0.00625|0.768;chr10_103947616_C_T|0.00625|0.768;chr10_103948417_T_A|0.00625|0.768;chr10_103952010_C_T|0.00624|0.768;chr10_103952090_A_G|0.00584|0.768;chr10_103954641_C_T|0.00473|0.767;chr10_103955167_A_G|0.00507|0.769;chr10_103955266_A_T|0.00502|0.769;chr10_103955584_C_T|0.00496|0.769;chr10_103957337_A_G|0.00486|0.77;chr10_103982043_GGTTAA_G|0.0358|0.962;chr10_104016203_C_T|0.00958|0.631;chr10_104049667_A_G|0.00621|0.907;chr10_104056375_A_G|0.0213|0.896;chr10_104056379_G_A|0.0213|0.896;chr10_104056927_T_C|0.0072|0.908;chr10_104057158_C_T|0.00769|0.908;chr10_104059440_A_G|0.0072|0.908;chr10_104060677_G_A|0.0072|0.908;chr10_104060747_T_G|0.0072|0.908;chr10_104061378_A_T|0.00725|0.908;chr10_104061536_A_G|0.00759|0.908;chr10_104062078_C_T|0.00725|0.908;chr10_104063351_T_C|0.00725|0.908;chr10_104066775_G_A|0.00953|0.911;chr10_104068723_C_A|0.00945|0.911;chr10_104072224_A_C|0.00964|0.913;chr10_104075920_G_A|0.00937|0.911;chr10_104077242_A_G|0.00937|0.911;chr10_104079082_C_A|0.00937|0.911;chr10_104079632_T_A|0.00929|0.911;chr10_104080361_C_G|0.00929|0.911;chr10_104084134_G_A|0.00914|0.911;chr10_104084785_G_C|0.00925|0.913;chr10_104085080_C_T|0.00925|0.913;chr10_104086316_A_G|0.00962|0.91;chr10_104088155_A_G|0.009|0.91;chr10_104088235_G_A|0.009|0.91;chr10_104092593_C_A|0.009|0.91;chr10_104094378_G_A|0.009|0.91;chr10_104095898_A_T|0.009|0.91;chr10_104097113_A_G|0.009|0.91;chr10_104100325_T_C|0.009|0.91;chr10_104100828_T_G|0.009|0.91;chr10_104104808_G_A|0.0097|0.91;chr10_104107966_G_T|0.00885|0.91;chr10_104108298_ACAGGTGTGTGC_A|0.00885|0.91;chr10_104110868_A_T|0.00822|0.909;chr10_104112816_A_G|0.00827|0.909;chr10_104125884_G_A|0.00804|0.909;chr10_104127793_T_TG|0.00804|0.909;chr10_104132892_A_G|0.00813|0.911;chr10_104133060_A_T|0.00798|0.909;chr10_104145081_C_T|0.00813|0.911;chr10_104147606_T_C|0.00807|0.911;chr10_104152448_A_C|0.00802|0.911;chr10_104164688_G_A|0.00497|0.906	2.64	uterine fibroid|0.992;telomere length|0.992;cardiac hypertrophy|0.91;red blood cell density measurement|0.769	uterine fibroid|0.992;telomere length|0.992;cardiac hypertrophy|0.91;red blood cell density measurement|0.769;mean arterial pressure|0.741;platelet count|0.731;mean corpuscular volume|0.542;mean corpuscular hemoglobin|0.542;white matter hyperintensity measurement|0.102;body height|0.102	NA
chr2_241273358_C_G	true	2	6.24e-9	8.21	-0.124	2.8395624511904765	0.040999999999999995	HDLBP	chr2_241195850_G_A|missense_variant|0.58	chr2_241177840_C_T|0.0363|0.522;chr2_241185166_G_A|0.0404|0.525;chr2_241195850_G_A|0.187|0.58;chr2_241245223_G_A|0.0952|0.908;chr2_241273358_C_G|0.371|1;chr2_241375608_A_G|0.0597|0.611;chr2_241405280_T_C|0.0939|0.911;chr2_241474676_C_T|0.0791|0.909	2.55	systolic blood pressure|0.911	systolic blood pressure|0.911;body height|0.185;hypothyroidism|0.125;Thyroid preparation use measurement|0.125	NA
chr5_146750201_A_G	true	5	6.409999999999999e-9	8.19	-0.11699999999999999	2.233980139655172	0.0491	PPP2R2B	NA	chr5_146719110_A_G|0.0293|0.589;chr5_146750201_A_G|0.557|1;chr5_146761144_C_T|0.381|0.999	2.31	NA	body mass index|0.234	NA
chr3_53376104_G_A	true	3	6.579999999999999e-9	8.18	0.0799	1.4065251067193678	0.10800000000000001	CACNA1D	NA	chr3_53295730_C_T|0.0843|0.881;chr3_53371164_C_T|0.00696|0.395;chr3_53376104_G_A|0.853|1;chr3_53523985_G_A|0.00628|0.0231	1.51	systolic blood pressure|0.0231;pulse pressure measurement|0.0231;cardiovascular disease|0.0231	anxiety|0.254;schizophrenia|0.211;resting heart rate|0.211;eosinophil count|0.204;blood metabolite measurement|0.176;glomerular filtration rate|0.147;worry measurement|0.139;wellbeing measurement|0.138;intelligence|0.135;smoking initiation|0.134;depressive symptom measurement|0.13;neuroticism measurement|0.13;heel bone mineral density|0.13;smoking status measurement|0.127;blood protein measurement|0.114;body height|0.105;systolic blood pressure|0.0231;pulse pressure measurement|0.0231;cardiovascular disease|0.0231	NA
chr3_14870125_GGAATGGCATGAGGGAGCCC_G	true	3	6.790000000000001e-9	8.17	-0.0538	1.0388497465988733	0.7090000000000001	FGD5	NA	chr3_14847738_A_T|0.00851|0.598;chr3_14848249_T_C|0.00852|0.598;chr3_14848425_TTGC_T|0.00188|0.212;chr3_14849148_C_T|0.0014|0.457;chr3_14849432_G_A|0.0014|0.457;chr3_14850291_T_C|0.00863|0.599;chr3_14851163_T_TG|0.00864|0.599;chr3_14851958_A_G|0.00192|0.213;chr3_14852633_C_T|0.00331|0.146;chr3_14853066_AG_A|0.00318|0.21;chr3_14853127_C_G|0.00322|0.21;chr3_14853598_G_C|0.0151|0.363;chr3_14853831_AAAGGACTAGGCTCATTTGGAGCCTAGTCCTTTGG_A|0.00378|0.211;chr3_14856183_A_G|0.00206|0.213;chr3_14857887_A_G|0.00174|0.455;chr3_14861884_T_C|0.00221|0.68;chr3_14864006_T_G|0.00208|0.68;chr3_14865227_C_T|0.00152|0.459;chr3_14866092_C_T|0.00152|0.459;chr3_14866759_G_A|0.0798|0.775;chr3_14869013_A_G|0.076|0.775;chr3_14869263_T_C|0.0701|0.774;chr3_14869637_C_T|0.0809|0.775;chr3_14869693_A_G|0.0814|0.775;chr3_14869718_A_T|0.0814|0.775;chr3_14869719_G_C|0.0814|0.775;chr3_14869756_A_G|0.0819|0.775;chr3_14869899_C_T|0.00284|0.681;chr3_14870061_C_T|0.0847|0.775;chr3_14870125_GGAATGGCATGAGGGAGCCC_G|0.118|1;chr3_14873217_A_G|0.00312|0.681;chr3_14878139_G_T|0.00187|0.459;chr3_14878946_T_A|0.00316|0.681;chr3_14881295_A_ACAGCCTGAACAT|0.00349|0.681;chr3_14881723_C_T|0.00215|0.459;chr3_14884722_C_T|0.0016|0.451;chr3_14891715_T_G|0.002|0.406;chr3_14895439_G_A|0.00123|0.347;chr3_14897691_G_A|0.0026|0.404;chr3_14897972_G_T|0.0013|0.347;chr3_14906632_G_A|0.0025|0.403;chr3_14907379_G_A|0.00276|0.403;chr3_14913166_A_C|0.0022|0.394;chr3_14914194_A_G|0.00186|0.403	2.76	hypertension|0.775;cardiovascular disease|0.459;erythrocyte count|0.451;red blood cell density measurement|0.451;mean arterial pressure|0.363;diastolic blood pressure|0.363;systolic blood pressure|0.363	hypertension|0.775;coronary artery disease|0.495;cardiovascular disease|0.459;red blood cell density measurement|0.451;erythrocyte count|0.451;pulse pressure measurement|0.38;diastolic blood pressure|0.363;systolic blood pressure|0.363;mean arterial pressure|0.363;hematocrit|0.15;hemoglobin measurement|0.15	NA
chr17_7209903_G_A	true	17	7.71e-9	8.11	0.0501	1.087144819380356	0.61	DLG4	NA	chr17_7199755_G_A|0.0918|0.795;chr17_7201008_C_G|0.0665|0.788;chr17_7206676_A_G|0.0856|0.783;chr17_7208305_T_C|0.0653|0.961;chr17_7209561_C_T|0.00683|0.898;chr17_7209903_G_A|0.347|1;chr17_7212835_C_T|0.0875|0.854;chr17_7213534_C_A|0.0862|0.854;chr17_7215003_A_G|0.0779|0.852;chr17_7229843_G_A|0.0183|0.542;chr17_7237287_A_G|0.0165|0.706;chr17_7261244_C_T|0.00559|0.699	2.62	birth weight|0.706;body height at birth|0.706	body height at birth|0.706;birth weight|0.706;systolic blood pressure|0.62;heel bone mineral density|0.582;eosinophil count|0.435	NA
chr21_43373584_A_G	false	21	7.87e-9	8.1	0.0501	0.7949448546686748	0.39399999999999996	NA	NA	chr21_43373584_A_G|0.183|1	1.96	NA	hair color|0.482;hair colour measurement|0.482	NA
chr16_5271769_C_T	true	16	7.99e-9	8.1	-0.0559	0.7417906792554627	0.257	RP11-420N3.3	NA	chr16_5271769_C_T|0.917|1;chr16_5272930_A_G|0.00242|0.888;chr16_5273710_T_C|0.00216|0.882;chr16_5274517_A_G|0.00169|0.883;chr16_5276003_T_G|0.00191|0.857;chr16_5277688_T_C|0.0039|0.843;chr16_5278777_A_G|0.00438|0.85;chr16_5283570_C_T|0.00282|0.865;chr16_5285365_A_AT|0.00251|0.862;chr16_5285597_C_T|0.00178|0.853;chr16_5287470_A_G|0.00209|0.857;chr16_5288208_G_A|0.00404|0.847;chr16_5290044_A_G|0.00429|0.817	1.54	NA	NA	NA
chr18_51250245_T_A	true	18	8.129999999999999e-9	8.09	1.06	1000000	0.000535	NA	NA	chr18_51250245_T_A|0.991|1	1.88	NA	NA	NA
chr1_3412095_C_T	true	1	8.35e-9	8.08	0.078	0.6974975379017586	0.109	PRDM16	chr1_3412095_C_T|missense_variant|1	chr1_3404570_G_A|0.0133|0.383;chr1_3408766_G_C|0.022|0.932;chr1_3409348_C_A|0.0209|0.923;chr1_3410232_C_G|0.0924|0.98;chr1_3410468_C_T|0.218|0.996;chr1_3411057_CAT_C|0.237|0.996;chr1_3412095_C_T|0.251|1;chr1_3412820_C_T|0.0693|0.979;chr1_3413696_C_T|0.0187|0.928;chr1_3424976_C_T|0.0195|0.166	2.38	hypertension|1;systolic blood pressure|1;diastolic blood pressure|1;rheumatoid arthritis|0.979;coronary artery disease|0.923;Agents acting on the renin-angiotensin system use measurement|0.923	hypertension|1;diastolic blood pressure|1;systolic blood pressure|1;rheumatoid arthritis|0.979;Agents acting on the renin-angiotensin system use measurement|0.923;coronary artery disease|0.923;body height|0.215	NA
chr9_35915060_C_T	true	9	9.01e-9	8.05	-0.0811	1.209855479603087	0.0997	LINC00961	chr9_35906522_G_A|missense_variant|0.248	chr9_35906522_G_A|0.152|0.248;chr9_35911916_T_A|0.212|0.999;chr9_35915060_C_T|0.261|1;chr9_35916475_T_C|0.232|1;chr9_35918781_C_T|0.00841|0.656;chr9_35920587_T_C|0.00865|0.657;chr9_35921638_T_C|0.00989|0.499;chr9_35922819_T_C|0.00865|0.657;chr9_35926941_G_A|0.00769|0.656;chr9_35927782_A_T|0.00859|0.656;chr9_35933388_C_T|0.00726|0.654;chr9_35937594_C_T|0.00762|0.654;chr9_35937889_C_T|0.00749|0.654;chr9_35945114_C_T|0.00824|0.653;chr9_35951142_C_T|0.00696|0.653;chr9_35952257_A_G|0.00706|0.651	2.37	NA	body height|0.112	NA
chr7_137368912_A_G	true	7	9.359999999999999e-9	8.03	-0.051	0.9466382583682008	0.35100000000000003	NA	NA	chr7_137355720_A_G|0.00804|0.618;chr7_137356202_A_G|0.00642|0.619;chr7_137356815_T_C|0.00749|0.619;chr7_137356923_T_G|0.00749|0.619;chr7_137356985_A_G|0.00756|0.619;chr7_137357031_A_C|0.00756|0.619;chr7_137357339_G_A|0.0142|0.626;chr7_137357876_G_A|0.0166|0.624;chr7_137358022_A_G|0.0138|0.625;chr7_137358507_G_C|0.0138|0.625;chr7_137358566_C_T|0.0154|0.624;chr7_137358578_A_T|0.0154|0.624;chr7_137358738_A_C|0.015|0.623;chr7_137359122_G_C|0.0153|0.624;chr7_137359786_C_T|0.0152|0.624;chr7_137359963_G_C|0.0154|0.624;chr7_137360440_C_T|0.0146|0.625;chr7_137360474_TC_T|0.0146|0.625;chr7_137360476_TC_T|0.0146|0.625;chr7_137360636_C_G|0.0146|0.625;chr7_137360639_G_A|0.0146|0.625;chr7_137361031_T_A|0.0156|0.625;chr7_137361688_G_T|0.0141|0.625;chr7_137363467_G_A|0.0123|0.626;chr7_137368912_A_G|0.54|1;chr7_137368958_T_C|0.0109|0.618;chr7_137369188_C_T|0.0111|0.628;chr7_137376726_C_T|0.0207|0.584;chr7_137377140_TAAC_T|0.0207|0.584;chr7_137377617_C_T|0.0204|0.584;chr7_137379102_ATTTTG_A|0.0223|0.62	1.59	NA	risk-taking behaviour|0.509;neuroticism measurement|0.469;insomnia measurement|0.469;blood protein measurement|0.315;schizophrenia|0.275;intelligence|0.272;self reported educational attainment|0.272;obsessive-compulsive disorder|0.206;anorexia nervosa|0.206;attention deficit hyperactivity disorder|0.206;unipolar depression|0.206;autism spectrum disorder|0.206;bipolar disorder|0.206;Tourette syndrome|0.206	NA
chr4_85788746_T_G	true	4	9.72e-9	8.01	0.0513	1.0203002451035257	0.33799999999999997	ARHGAP24	NA	chr4_85782142_T_C|0.192|1;chr4_85782942_A_C|0.0618|0.796;chr4_85788594_C_T|0.194|1;chr4_85788746_T_G|0.206|1;chr4_85789125_A_T|0.0162|0.828;chr4_85790567_C_T|0.189|1;chr4_85797697_A_G|0.0445|0.539;chr4_85798012_T_C|0.0209|0.334;chr4_85801950_T_A|0.00766|0.309;chr4_85804531_T_C|0.00762|0.309;chr4_85804806_A_T|0.00762|0.309;chr4_85809561_C_T|0.00887|0.258	1.79	systolic blood pressure|0.309;heel bone mineral density|0.309	systolic blood pressure|0.41;pulse pressure measurement|0.41;Systolic Blood Pressure|0.41;heel bone mineral density|0.309	NA
chr5_158399273_G_A	true	5	1.1200000000000001e-8	7.95	-0.0494	0.8899229300446523	0.391	RP11-524N5.1	NA	chr5_158376326_C_T|0.00638|0.99;chr5_158376580_A_G|0.00448|0.99;chr5_158376622_G_A|0.00289|0.81;chr5_158377162_T_TG|0.00568|0.991;chr5_158377449_C_T|0.00284|0.792;chr5_158379242_G_A|0.00336|0.792;chr5_158380193_T_A|0.00638|0.99;chr5_158380787_G_A|0.00636|0.99;chr5_158382753_C_T|0.00647|0.991;chr5_158383828_A_G|0.0113|0.999;chr5_158384033_C_CT|0.0111|0.999;chr5_158384080_A_T|0.00312|0.793;chr5_158384407_A_C|0.0113|0.999;chr5_158386005_T_C|0.00312|0.793;chr5_158386140_A_G|0.00292|0.793;chr5_158386459_A_T|0.00526|0.991;chr5_158386865_C_T|0.00526|0.991;chr5_158389037_T_G|0.00526|0.991;chr5_158390600_A_G|0.0113|0.999;chr5_158391072_C_T|0.00526|0.991;chr5_158391866_G_A|0.00526|0.991;chr5_158392616_A_G|0.00307|0.793;chr5_158395244_G_A|0.00526|0.991;chr5_158395246_T_C|0.00526|0.991;chr5_158395668_C_G|0.00526|0.991;chr5_158396949_C_A|0.00521|0.991;chr5_158397548_G_A|0.00312|0.793;chr5_158398988_T_C|0.00511|0.991;chr5_158399114_C_T|0.005|0.991;chr5_158399245_G_A|0.0112|1;chr5_158399273_G_A|0.0125|1;chr5_158400233_A_C|0.0107|1;chr5_158400378_G_A|0.0108|0.999;chr5_158400509_A_G|0.0111|1;chr5_158401218_A_C|0.00502|0.991;chr5_158402678_G_A|0.00511|0.991;chr5_158403039_A_G|0.00511|0.991;chr5_158405292_A_G|0.00829|0.995;chr5_158405741_G_A|0.00312|0.793;chr5_158406009_T_C|0.00511|0.991;chr5_158406985_G_C|0.0111|1;chr5_158407612_T_C|0.00511|0.991;chr5_158407623_G_C|0.0111|1;chr5_158407873_A_T|0.0111|1;chr5_158408485_G_A|0.0104|0.998;chr5_158410759_T_C|0.0111|1;chr5_158411534_G_A|0.00328|0.793;chr5_158413562_A_G|0.00417|0.982;chr5_158416946_GTGACAGTGCAAGGTGGGGGCT_G|0.0102|0.989;chr5_158417097_G_A|0.00289|0.788;chr5_158417527_T_C|0.00473|0.981;chr5_158417548_C_T|0.00473|0.981;chr5_158417878_G_A|0.00473|0.981;chr5_158420064_G_A|0.0106|0.989;chr5_158420184_A_C|0.0106|0.989;chr5_158420351_T_C|0.0106|0.989;chr5_158422287_G_A|0.00308|0.788;chr5_158424413_T_G|0.0106|0.989;chr5_158424572_C_T|0.0106|0.989;chr5_158425323_T_C|0.0106|0.989;chr5_158425798_A_G|0.00489|0.981;chr5_158426514_G_A|0.0106|0.989;chr5_158427884_A_G|0.0062|0.96;chr5_158428645_T_C|0.0106|0.989;chr5_158429561_A_T|0.0107|0.989;chr5_158429768_G_A|0.0107|0.989;chr5_158429798_G_A|0.0107|0.989;chr5_158430010_C_CA|0.0107|0.989;chr5_158430418_G_T|0.00497|0.981;chr5_158431003_G_T|0.0107|0.989;chr5_158432272_A_T|0.00501|0.98;chr5_158432625_T_C|0.0107|0.989;chr5_158432959_C_T|0.0107|0.989;chr5_158433631_A_G|0.0107|0.989;chr5_158433805_G_A|0.00497|0.981;chr5_158434455_G_A|0.0107|0.989;chr5_158434831_C_T|0.0107|0.989;chr5_158434957_A_G|0.00895|0.988;chr5_158435384_T_G|0.0107|0.989;chr5_158435419_A_G|0.0107|0.989;chr5_158435607_G_A|0.0107|0.989;chr5_158436000_C_T|0.0107|0.989;chr5_158436296_G_A|0.0107|0.989;chr5_158436306_A_T|0.0107|0.989;chr5_158436577_G_A|0.0107|0.989;chr5_158437119_T_A|0.011|0.989;chr5_158437298_C_CTA|0.00508|0.981;chr5_158437326_A_G|0.0105|0.989;chr5_158439028_T_G|0.00894|0.988;chr5_158439459_C_T|0.00416|0.98;chr5_158439622_C_T|0.00416|0.98;chr5_158439801_A_G|0.00894|0.988;chr5_158439868_C_G|0.00894|0.988;chr5_158439941_C_T|0.00894|0.988;chr5_158440587_C_T|0.00776|0.989;chr5_158440702_C_T|0.00785|0.99;chr5_158441304_C_T|0.00785|0.99;chr5_158441550_A_G|0.00806|0.989;chr5_158442449_T_G|0.00785|0.99;chr5_158443043_T_C|0.00785|0.99;chr5_158443129_C_T|0.00785|0.99;chr5_158443162_A_G|0.00785|0.99;chr5_158443534_T_C|0.00785|0.99;chr5_158443934_A_T|0.00785|0.99;chr5_158444133_C_T|0.00732|0.989;chr5_158444676_C_T|0.00833|0.989;chr5_158445530_G_GC|0.00785|0.99;chr5_158446080_T_C|0.00404|0.98;chr5_158446210_T_C|0.00785|0.99;chr5_158446519_C_T|0.00366|0.981;chr5_158446622_A_G|0.00363|0.981;chr5_158448223_C_T|0.00708|0.989;chr5_158448385_C_T|0.00785|0.99;chr5_158448578_G_C|0.00366|0.981;chr5_158449351_C_G|0.00785|0.99;chr5_158449367_C_T|0.00785|0.99;chr5_158449386_C_G|0.00748|0.989;chr5_158449397_G_C|0.00785|0.99;chr5_158449466_T_G|0.00366|0.981;chr5_158449578_T_C|0.00785|0.99;chr5_158449774_C_T|0.00554|0.985;chr5_158449876_T_C|0.00785|0.99;chr5_158449900_C_G|0.00785|0.99;chr5_158450060_T_C|0.0079|0.989;chr5_158450445_G_C|0.00951|0.944;chr5_158451041_C_A|0.00971|0.974	2.01	balding measurement|0.974;alcohol drinking|0.944;mean arterial pressure|0.944;Beta blocking agent use measurement|0.81;alcohol consumption measurement|0.793;systolic blood pressure|0.793	balding measurement|0.974;mean arterial pressure|0.944;alcohol drinking|0.944;systolic blood pressure|0.832;longevity|0.832;Calcium channel blocker use measurement|0.829;Diuretic use measurement|0.829;Agents acting on the renin-angiotensin system use measurement|0.829;cardiovascular disease|0.829;Beta blocking agent use measurement|0.81;alcohol consumption measurement|0.793;BMI-adjusted waist-hip ratio|0.585;smoking status measurement|0.357;smoking initiation|0.32;creatine kinase measurement|0.244	NA
chr12_20198342_A_T	true	12	1.14e-8	7.94	-0.0584	0.5770389574528036	0.21899999999999997	NA	NA	chr12_20198342_A_T|0.372|1;chr12_20207394_A_G|0.3|0.977;chr12_20215335_T_C|0.168|0.891;chr12_20220607_A_G|0.135|0.895	2.48	cardiovascular disease|0.977;systolic blood pressure|0.895;Agents acting on the renin-angiotensin system use measurement|0.895;diastolic blood pressure|0.891	cardiovascular disease|0.977;Agents acting on the renin-angiotensin system use measurement|0.895;systolic blood pressure|0.895;diastolic blood pressure|0.891;smoking status measurement|0.659	NA
chr1_24809712_C_T	true	1	1.1699999999999999e-8	7.93	0.0587	1.6134026555323593	0.215	CLIC4	NA	chr1_24705677_G_A|0.00275|0.692;chr1_24713824_C_T|0.0034|0.687;chr1_24716802_C_T|0.00279|0.693;chr1_24717620_C_T|0.00323|0.692;chr1_24720968_C_T|0.00247|0.694;chr1_24723458_A_G|0.00252|0.692;chr1_24723737_G_A|0.00236|0.691;chr1_24724338_G_A|0.00256|0.692;chr1_24724765_T_TG|0.0025|0.692;chr1_24727732_C_G|0.00265|0.686;chr1_24739957_T_C|0.00287|0.709;chr1_24743739_A_G|0.00283|0.709;chr1_24747080_A_C|0.00288|0.711;chr1_24749310_A_C|0.00309|0.71;chr1_24751486_G_GC|0.00319|0.71;chr1_24751570_T_C|0.00315|0.71;chr1_24751837_C_A|0.00315|0.71;chr1_24755174_G_C|0.00338|0.712;chr1_24763955_G_C|0.00313|0.713;chr1_24767742_G_T|0.00275|0.71;chr1_24768223_T_C|0.00313|0.713;chr1_24770901_A_G|0.00313|0.713;chr1_24771754_T_C|0.00313|0.713;chr1_24771850_C_T|0.00313|0.713;chr1_24772947_G_T|0.00313|0.713;chr1_24776788_TGTAGTCCCAGCTACTCGGGAG_T|0.00313|0.713;chr1_24786996_C_G|0.00491|0.71;chr1_24787739_G_T|0.00309|0.71;chr1_24795383_A_G|0.00385|0.712;chr1_24795671_A_G|0.00381|0.711;chr1_24796348_C_G|0.00385|0.712;chr1_24797499_G_A|0.00377|0.712;chr1_24798671_C_G|0.00429|0.711;chr1_24799407_C_G|0.00376|0.711;chr1_24799569_C_T|0.00272|0.71;chr1_24803592_T_C|0.0039|0.712;chr1_24804292_T_C|0.00364|0.71;chr1_24808513_C_T|0.00376|0.712;chr1_24809712_C_T|0.727|1;chr1_24810222_A_G|0.00397|0.712;chr1_24813758_G_A|0.00394|0.712;chr1_24814334_A_G|0.00367|0.712;chr1_24820719_TTCTC_T|0.00393|0.712;chr1_24821259_G_A|0.00393|0.712;chr1_24821800_G_T|0.00393|0.712;chr1_24821876_G_A|0.00393|0.712;chr1_24822195_G_A|0.00396|0.712;chr1_24832009_T_C|0.00396|0.711;chr1_24835171_C_T|0.0039|0.712;chr1_24835953_T_G|0.00388|0.712;chr1_24836682_A_T|0.00389|0.712;chr1_24837622_A_G|0.0042|0.711;chr1_24838287_G_T|0.00388|0.712;chr1_24841633_G_C|0.00384|0.712;chr1_24843143_A_G|0.00357|0.712;chr1_24844597_A_G|0.00329|0.712;chr1_24845228_G_C|0.00312|0.711;chr1_24846061_AAATTC_A|0.003|0.712;chr1_24846153_CTG_C|0.00338|0.712;chr1_24846546_T_C|0.00307|0.712;chr1_24848755_A_G|0.00292|0.712;chr1_24850081_C_T|0.00271|0.712;chr1_24850548_T_A|0.0028|0.712;chr1_24851494_C_A|0.00263|0.711;chr1_24853830_G_A|0.00212|0.708;chr1_24854645_G_A|0.00209|0.707;chr1_24854719_G_C|0.00212|0.708;chr1_24856057_T_G|0.00216|0.707;chr1_24858706_T_C|0.00257|0.638;chr1_24902816_G_A|0.00212|0.323	1.89	platelet crit|0.692;hematocrit|0.692;hemoglobin measurement|0.692;body height|0.692	hemoglobin measurement|0.692;hematocrit|0.692;body height|0.692;platelet crit|0.692;systolic blood pressure|0.629;erythrocyte count|0.629;high density lipoprotein cholesterol measurement|0.629;asthma|0.23;balding measurement|0.165;allergy|0.14;Eczema|0.139;allergic rhinitis|0.139;eosinophil count|0.135	NA
chr11_61505093_T_C	true	11	1.27e-8	7.9	-0.0639	1.4930247552	0.17	LRRC10B	NA	chr11_61504837_C_T|0.0468|0.441;chr11_61505093_T_C|0.328|1;chr11_61509559_C_T|0.13|0.418;chr11_61510226_A_G|0.0558|0.968;chr11_61510303_A_G|0.0553|0.968;chr11_61510413_G_A|0.0529|0.968;chr11_61510774_T_C|0.205|0.996;chr11_61511118_C_T|0.0548|0.967;chr11_61511446_C_T|0.0584|0.966	2.08	hypertension|0.968;alcohol drinking|1;diastolic blood pressure|1;mean arterial pressure|1;systolic blood pressure|1;cardiovascular disease|1;smoking status measurement|0.996;Agents acting on the renin-angiotensin system use measurement|0.996;Mean Arterial Pressure|0.996;heel bone mineral density|0.968	hypertension|0.968;alcohol drinking|1;cardiovascular disease|1;diastolic blood pressure|1;mean arterial pressure|1;systolic blood pressure|1;Agents acting on the renin-angiotensin system use measurement|0.996;Mean Arterial Pressure|0.996;smoking status measurement|0.996;heel bone mineral density|0.968;self reported educational attainment|0.149;phosphatidylcholine measurement|0.129;esterified cholesterol measurement|0.129	NA
chr6_11211245_G_A	true	6	1.3600000000000001e-8	7.87	0.557	0.27421272	0.00202	NEDD9	NA	chr6_10802397_C_G|0.00594|0.312;chr6_11204522_C_A|0.0411|0.83;chr6_11211245_G_A|0.802|1;chr6_11822356_T_A|0.0345|0.128;chr6_11842458_T_A|0.0718|0.134	1.76	NA	NA	NA
chr7_140360978_A_C	true	7	1.3899999999999999e-8	7.86	0.462	1000000	0.0030399999999999997	SLC37A3	NA	chr7_140360978_A_C|0.963|1	1.42	NA	NA	NA
chr19_1822669_T_C	true	19	1.6799999999999998e-8	7.77	-0.0585	1.0259463218903255	0.21	REXO1	chr19_1825928_TCTC_T|inframe_indel|0.989	chr19_1822669_T_C|0.0528|1;chr19_1825402_A_G|0.0371|0.989;chr19_1825663_A_G|0.0407|0.989;chr19_1825928_TCTC_T|0.0407|0.989;chr19_1826113_A_G|0.0391|0.989;chr19_1826165_G_T|0.0513|0.968;chr19_1826684_GGCAACAGGA_G|0.0408|0.989;chr19_1828949_A_C|0.0285|0.99;chr19_1829861_T_C|0.0229|0.99;chr19_1832318_G_A|0.0392|0.992;chr19_1835626_C_T|0.0389|0.992;chr19_1835953_A_C|0.039|0.992;chr19_1840268_A_G|0.0396|0.991;chr19_1842885_G_A|0.0391|0.991;chr19_1842920_A_G|0.0391|0.991;chr19_1847699_A_C|0.0299|0.989;chr19_1848629_A_G|0.03|0.989;chr19_1848958_A_G|0.028|0.989;chr19_1849888_G_C|0.0167|0.986;chr19_1849968_T_G|0.025|0.987;chr19_1850896_A_G|0.0224|0.987;chr19_1851085_A_G|0.0221|0.987;chr19_1852495_C_T|0.0333|0.963;chr19_1852583_A_G|0.0317|0.962;chr19_1852838_A_G|0.018|0.975;chr19_1854558_A_G|0.0238|0.904;chr19_1854936_C_G|0.00845|0.903;chr19_1855332_G_A|0.0199|0.907;chr19_1855335_T_C|0.0254|0.906;chr19_1859391_A_C|0.0071|0.843;chr19_1860148_G_A|0.00425|0.792;chr19_1864279_AC_A|0.00362|0.769;chr19_1866164_C_T|0.0118|0.745	1.84	cardiovascular disease|0.992	cardiovascular disease|0.992;body mass index|0.9;urate measurement|0.886;FEV/FEC ratio|0.854;mathematical ability|0.721;cognitive function measurement|0.721;self reported educational attainment|0.721;age at menarche|0.201;red blood cell distribution width|0.144	NA
chr23_53834837_G_A	true	23	1.74e-8	7.76	-0.0682	NA	0.0911	NA	NA	chr23_53741181_A_ATTTC|0.144|0.939;chr23_53786288_A_G|0.205|0.938;chr23_53834837_G_A|0.642|1	3.09	NA	NA	NA
chr1_169483011_ATC_A	true	1	1.79e-8	7.75	0.889	1000000	0.00105	SLC19A2	NA	chr1_169483011_ATC_A|0.991|1	1.84	NA	NA	NA
chr8_9379893_G_T	false	8	1.86e-8	7.73	-0.0482	0.8363843895055498	0.493	RP11-115J16.1	NA	chr8_9379893_G_T|0.505|1	1.34	NA	neuroticism measurement|0.342;diet measurement|0.274;type II diabetes mellitus|0.255;alcohol drinking|0.179;pulse pressure measurement|0.179;alcohol consumption measurement|0.166;systolic blood pressure|0.166;triglyceride measurement|0.166;risky sexual behaviour measurement|0.162;diastolic blood pressure|0.161;smoking status measurement|0.16;BMI-adjusted waist-hip ratio|0.157;neurotic disorder|0.157;wellbeing measurement|0.157;mean arterial pressure|0.157;glomerular filtration rate|0.155;appendicular lean mass|0.154;age at first sexual intercourse measurement|0.154;heel bone mineral density|0.153;Agents acting on the renin-angiotensin system use measurement|0.15;C-reactive protein measurement|0.144;systemic lupus erythematosus|0.144;mathematical ability|0.144;mood instability measurement|0.138;nose morphology measurement|0.133;body mass index|0.133;osteoarthritis, hip|0.133;high density lipoprotein cholesterol measurement|0.131;self reported educational attainment|0.129;chronotype measurement|0.126;mean corpuscular hemoglobin|0.126;mean corpuscular volume|0.126;mean corpuscular hemoglobin concentration|0.126;risk-taking behaviour|0.125;red blood cell distribution width|0.124;joint hypermobility measurement|0.123;white matter microstructure measurement|0.12;TPE interval measurement|0.116;schizophrenia|0.115;social interaction measurement|0.114;Type 2 Diabetes Mellitus|0.113;platelet component distribution width|0.104;mean platelet volume|0.104;reticulocyte count|0.104;basophil count|0.102	NA
chr3_29324673_T_C	true	3	1.93e-8	7.71	-0.0533	1.0353225319234374	0.726	RBMS3	NA	chr3_29324673_T_C|0.966|1	1.48	NA	NA	NA
chr6_34917487_T_TA	true	6	2e-8	7.7	0.19699999999999998	2.1206118000000003	0.015	ANKS1A	NA	chr6_34917487_T_TA|0.901|1;chr6_35267954_C_T|0.0352|0.797;chr6_35296373_C_T|0.0347|0.797	1.56	NA	body mass index|0.1	NA
chr3_155575901_T_C	true	3	2.64e-8	7.58	0.836	3.1185325	0.000938	PLCH1	NA	chr3_155575901_T_C|0.978|1	1.55	NA	NA	NA
chr6_51148404_G_GA	true	6	2.71e-8	7.57	0.0473	NA	0.505	NA	NA	chr6_51104094_C_T|0.0136|0.99;chr6_51105935_C_T|0.0161|0.992;chr6_51110277_C_G|0.00876|0.809;chr6_51112336_C_A|0.00879|0.809;chr6_51115049_T_C|0.0115|0.813;chr6_51117218_C_T|0.0114|0.813;chr6_51120659_G_A|0.0114|0.813;chr6_51122408_C_T|0.0112|0.813;chr6_51124688_T_C|0.0109|0.813;chr6_51131688_T_C|0.0102|0.813;chr6_51132310_T_A|0.0101|0.813;chr6_51133350_A_AT|0.00998|0.814;chr6_51135561_A_G|0.011|0.814;chr6_51140957_CTA_C|0.0108|0.814;chr6_51142173_A_G|0.0102|0.815;chr6_51142594_C_G|0.00927|0.81;chr6_51143798_A_G|0.00998|0.815;chr6_51148404_G_GA|0.0255|1;chr6_51149152_T_C|0.0255|1;chr6_51150322_C_CT|0.0252|1;chr6_51157319_A_G|0.0245|1;chr6_51158792_A_G|0.0248|1;chr6_51163450_A_G|0.0239|1;chr6_51164398_T_C|0.0238|1;chr6_51164840_A_G|0.0228|1;chr6_51165934_A_T|0.0233|1;chr6_51167075_A_G|0.0233|1;chr6_51169806_T_C|0.0236|0.999;chr6_51169876_T_A|0.0227|0.999;chr6_51170134_C_T|0.0227|0.999;chr6_51170273_AT_A|0.0227|0.999;chr6_51170589_A_G|0.0218|0.999;chr6_51170899_G_C|0.022|0.999;chr6_51171294_C_CAAAG|0.0225|0.999;chr6_51171295_T_TTA|0.0225|0.999;chr6_51171297_C_A|0.0225|0.999;chr6_51171305_TA_T|0.0225|0.999;chr6_51171945_T_C|0.0227|0.899;chr6_51171948_A_G|0.0213|0.999;chr6_51172069_C_T|0.0215|0.999;chr6_51172146_T_TA|0.0231|0.999;chr6_51172416_A_G|0.0223|0.999;chr6_51172592_C_T|0.0223|0.999;chr6_51173590_C_A|0.024|0.998;chr6_51174053_G_C|0.0209|0.999;chr6_51176497_C_T|0.0215|0.999;chr6_51177076_A_T|0.0217|0.999;chr6_51178837_TTGTGA_T|0.0216|0.998;chr6_51179802_G_A|0.0211|0.999;chr6_51183772_T_G|0.0131|0.996;chr6_51185685_A_C|0.0128|0.996;chr6_51191804_G_A|0.0122|0.995	2.58	NA	blood urea nitrogen measurement|0.764;body mass index|0.381;chronotype measurement|0.155;smoking behavior|0.148;obesity|0.148;lean body mass|0.148;waist circumference|0.148;physical activity measurement|0.148;Agents acting on the renin-angiotensin system use measurement|0.141;hip circumference|0.122;Type 2 Diabetes Mellitus|0.122;waist-hip ratio|0.121;type II diabetes mellitus|0.121;Drugs used in diabetes use measurement|0.121;visceral adipose tissue measurement|0.115	NA
chr9_38288405_A_T	true	9	3.01e-8	7.52	-0.0614	0.8919025170998632	0.182	NA	NA	chr9_38288405_A_T|0.965|1	1.37	NA	NA	NA
chr7_1857054_C_T	true	7	3.21e-8	7.49	-0.0533	1.4454285285714286	0.26	MAD1L1	chr7_1838741_A_G|start_lost|0.97	chr7_1833285_C_T|0.00926|0.911;chr7_1833770_C_A|0.008|0.91;chr7_1834120_C_G|0.018|0.968;chr7_1837675_T_C|0.0182|0.969;chr7_1838741_A_G|0.019|0.97;chr7_1840207_A_G|0.0233|0.971;chr7_1841891_G_C|0.0255|0.972;chr7_1843159_G_A|0.0273|0.972;chr7_1843638_T_C|0.0123|0.956;chr7_1845194_G_C|0.00917|0.868;chr7_1845301_A_G|0.0294|0.973;chr7_1845964_A_G|0.00918|0.868;chr7_1847169_A_G|0.0092|0.868;chr7_1847401_T_C|0.0241|0.974;chr7_1848415_G_A|0.0243|0.974;chr7_1849664_G_A|0.0296|0.975;chr7_1850366_C_T|0.0233|0.975;chr7_1851379_C_T|0.0117|0.973;chr7_1851679_C_T|0.0273|0.976;chr7_1852087_C_G|0.0233|0.975;chr7_1852673_C_T|0.022|0.974;chr7_1852893_C_T|0.0239|0.974;chr7_1855827_T_G|0.0484|0.978;chr7_1857054_C_T|0.0786|1;chr7_1858125_T_C|0.0221|0.906;chr7_1866830_G_A|0.00905|0.839;chr7_1871822_A_C|0.0081|0.88;chr7_1873634_G_A|0.00712|0.882;chr7_1874423_T_C|0.00517|0.842;chr7_1875043_A_C|0.00485|0.842;chr7_1875045_G_A|0.0052|0.842;chr7_1875361_G_C|0.00522|0.842;chr7_1875646_C_A|0.00515|0.842;chr7_1875787_G_A|0.00515|0.842;chr7_1875857_A_C|0.00522|0.842;chr7_1876188_C_G|0.00523|0.842;chr7_1876480_T_A|0.00523|0.842;chr7_1877508_C_T|0.00511|0.883;chr7_1877999_A_T|0.00557|0.842;chr7_1878443_T_C|0.00567|0.841;chr7_1880720_G_A|0.005|0.88;chr7_1881726_C_T|0.00716|0.84;chr7_1887000_G_A|0.00601|0.88;chr7_1888381_T_TATACGTGTGTGTGC|0.0116|0.867;chr7_1888390_G_GGCTGCC|0.0105|0.874;chr7_1889383_G_T|0.00574|0.88;chr7_1893280_TGGG_T|0.00522|0.879;chr7_1893284_AAGTCCTGGCTGGGATG_A|0.00522|0.879;chr7_1895962_T_C|0.00687|0.878;chr7_1896352_T_C|0.00684|0.878;chr7_1897302_G_A|0.00591|0.877;chr7_1899385_T_C|0.00652|0.877;chr7_1901367_T_C|0.00654|0.877;chr7_1901415_C_T|0.00654|0.877;chr7_1905806_C_G|0.00583|0.877;chr7_1905832_C_T|0.00597|0.877;chr7_1906494_C_G|0.00583|0.877;chr7_1908818_C_T|0.00718|0.865;chr7_1910335_G_T|0.00726|0.865;chr7_1910701_G_A|0.00734|0.865;chr7_1911173_C_T|0.00603|0.866;chr7_1912503_T_C|0.0101|0.865;chr7_1913780_G_A|0.0351|0.769;chr7_1913979_G_A|0.0352|0.769;chr7_1922178_C_A|0.00483|0.876;chr7_1922246_C_A|0.00483|0.876;chr7_1922527_G_T|0.00508|0.875;chr7_1923485_A_ACCC|0.00734|0.824;chr7_1924721_A_T|0.00548|0.869;chr7_1934334_C_T|0.0134|0.777;chr7_1938366_T_C|0.019|0.774;chr7_1939833_GA_G|0.00885|0.755	2.53	gastroesophageal reflux disease|0.969;type II diabetes mellitus|0.911;body mass index|0.911;bipolar disorder|0.866	gastroesophageal reflux disease|0.969;type II diabetes mellitus|0.911;body mass index|0.911;bipolar disorder|0.866	NA
chr9_126894544_G_C	false	9	3.21e-8	7.49	0.0969	1.5714057204030225	0.0623	NA	NA	chr9_126894544_G_C|0.31|1	1.53	NA	heel bone mineral density|0.121	NA
chr13_65932071_C_T	true	13	3.32e-8	7.48	-0.381	0.7793448218181817	0.00394	NA	NA	chr13_65932071_C_T|0.952|1	1.48	NA	NA	NA
chr1_154703044_G_A	true	1	3.41e-8	7.47	-0.105	0.8053568691588786	0.0531	KCNN3	NA	chr1_154703044_G_A|0.974|1	1.58	NA	mean corpuscular hemoglobin|0.108;interleukin 6 receptor subunit alpha measurement|0.108	NA
chr5_96845717_T_TACTC	true	5	4.0199999999999996e-8	7.4	0.0591	1.0258207243873978	0.8079999999999999	CTD-2260A17.2	chr5_96788627_T_C|missense_variant|0.257	chr5_96744764_C_T|0.0026|0.449;chr5_96780017_C_T|0.00172|0.647;chr5_96781596_G_A|0.00168|0.659;chr5_96783875_A_ACT|0.00174|0.659;chr5_96784350_G_C|0.00175|0.659;chr5_96784751_C_T|0.00182|0.659;chr5_96786011_C_T|0.00208|0.257;chr5_96786290_A_G|0.00204|0.257;chr5_96786556_T_G|0.002|0.257;chr5_96786577_A_C|0.002|0.257;chr5_96787352_A_G|0.00828|0.507;chr5_96787385_C_T|0.00177|0.257;chr5_96787422_T_C|0.00176|0.257;chr5_96787457_T_C|0.00833|0.507;chr5_96787507_C_T|0.00174|0.257;chr5_96787561_C_A|0.00174|0.257;chr5_96787633_T_C|0.00171|0.257;chr5_96787963_G_T|0.00168|0.257;chr5_96788627_T_C|0.00153|0.257;chr5_96788744_G_C|0.00769|0.507;chr5_96789256_T_G|0.00763|0.507;chr5_96789762_G_A|0.00756|0.508;chr5_96790207_C_T|0.00159|0.257;chr5_96790494_A_G|0.00157|0.257;chr5_96790605_A_G|0.00148|0.257;chr5_96792202_T_C|0.0075|0.508;chr5_96792697_G_T|0.00728|0.508;chr5_96793809_A_G|0.00869|0.508;chr5_96794311_T_C|0.00743|0.508;chr5_96794312_G_C|0.00743|0.508;chr5_96796030_G_A|0.00743|0.508;chr5_96797724_C_T|0.00745|0.508;chr5_96798009_A_C|0.00865|0.506;chr5_96798217_C_T|0.00357|0.506;chr5_96798410_A_G|0.00745|0.508;chr5_96802101_A_G|0.00793|0.511;chr5_96802137_A_G|0.00793|0.511;chr5_96802179_A_G|0.00791|0.511;chr5_96803064_T_C|0.00793|0.511;chr5_96803109_A_G|0.00793|0.511;chr5_96803158_C_T|0.00779|0.511;chr5_96812074_T_C|0.0114|0.512;chr5_96816265_C_A|0.0159|0.527;chr5_96819615_C_T|0.0121|0.809;chr5_96826239_T_G|0.0208|0.528;chr5_96827664_A_AAAAT|0.00207|0.67;chr5_96831833_T_C|0.0186|0.811;chr5_96837436_C_T|0.00152|0.944;chr5_96838483_A_G|0.0536|0.994;chr5_96839523_G_A|0.0617|1;chr5_96841147_T_A|0.0623|1;chr5_96843643_C_T|0.0594|1;chr5_96845505_A_G|0.0627|1;chr5_96845594_G_A|0.0441|0.819;chr5_96845717_T_TACTC|0.0627|1;chr5_96847014_G_A|0.00305|0.519;chr5_96848322_A_G|0.0434|0.819;chr5_96848899_T_TG|0.0434|0.819;chr5_96852380_T_C|0.0428|0.819;chr5_96852963_A_G|0.0012|0.372;chr5_96856044_A_G|0.0428|0.82;chr5_96856117_G_A|0.0423|0.819;chr5_96859577_A_G|0.0475|0.819	2.38	systolic blood pressure|0.994;Calcium channel blocker use measurement|0.647;endoplasmic reticulum aminopeptidase 1 measurement|0.511;ankylosing spondylitis|0.257;psoriasis|0.257;ulcerative colitis|0.257;Crohn's disease|0.257;sclerosing cholangitis|0.257;Ankylosing Spondylitis|0.257;cerebrospinal fluid biomarker measurement|0.257	systolic blood pressure|0.994;Calcium channel blocker use measurement|0.647;cardiovascular disease|0.622;endoplasmic reticulum aminopeptidase 1 measurement|0.511;body mass index|0.377;psoriasis|0.311;Psoriaris|0.311;Ankylosing Spondylitis|0.257;cerebrospinal fluid biomarker measurement|0.257;ulcerative colitis|0.257;Crohn's disease|0.257;sclerosing cholangitis|0.257;ankylosing spondylitis|0.257;neutrophil count|0.135;blood protein measurement|0.135;myeloid white cell count|0.105	NA
chr9_110000226_T_C	false	9	4.21e-8	7.38	-0.0595	0.9950370195684898	0.18600000000000003	PALM2-AKAP2	NA	chr9_110000226_T_C|1.04e-05|1	0.253	NA	NA	NA
chr4_85412170_G_C	true	4	4.36e-8	7.36	-0.159	54.34259066666666	0.0226	NA	NA	chr4_84535990_A_T|0.0522|0.888;chr4_84549554_T_C|0.0525|0.888;chr4_84739175_C_G|0.096|0.92;chr4_84774070_A_T|0.0963|0.92;chr4_84824725_G_A|0.1|0.922;chr4_84899605_C_T|0.102|0.922;chr4_85102576_A_G|0.118|0.952;chr4_85248003_T_C|0.113|0.98;chr4_85327200_C_T|0.033|0.964;chr4_85412170_G_C|0.155|1;chr4_85525205_T_C|0.0413|0.621	1.33	NA	type II diabetes mellitus|0.251	NA
chr4_26792059_A_C	true	4	4.3899999999999996e-8	7.36	0.0464	1.2073175140664962	0.48	NA	NA	chr4_26786123_C_G|0.0446|0.32;chr4_26790209_T_C|0.0442|0.321;chr4_26792059_A_C|0.1|1;chr4_26793981_T_C|0.0312|0.318;chr4_26794784_A_G|0.0391|0.32;chr4_26795262_CCTT_C|0.04|0.322;chr4_26796037_G_A|0.0921|0.997;chr4_26797768_A_G|0.0836|0.998;chr4_26799951_T_TA|0.0799|0.998;chr4_26799952_T_A|0.075|0.998;chr4_26800405_T_C|0.0367|0.32;chr4_26803771_G_A|0.0652|0.996;chr4_26805114_C_T|0.0355|0.987;chr4_26807207_C_T|0.0435|0.99;chr4_26807397_C_T|0.0215|0.32;chr4_26807493_A_G|0.0208|0.32;chr4_26810588_C_T|0.0232|0.321;chr4_26811115_C_T|0.0412|0.986;chr4_26811534_G_A|0.0227|0.321;chr4_26812337_C_T|0.0245|0.321	2.58	systolic blood pressure|0.986	systolic blood pressure|0.986;diastolic blood pressure|0.951;Agents acting on the renin-angiotensin system use measurement|0.951;Varicose veins|0.242;cardiovascular disease|0.213	NA
chr23_112146252_AAGAG_A	true	23	4.77e-8	7.32	0.7170000000000001	2.8723266866666664	0.000791	NA	NA	chr23_112087755_G_A|0.153|0.992;chr23_112146252_AAGAG_A|0.407|1;chr23_112397258_G_A|0.0313|0.72;chr23_112717150_G_A|0.38|0.778	1.85	NA	NA	NA
chr5_63657894_G_A	true	5	4.98e-8	7.3	1.2	0.623130042	0.000379	NA	NA	chr5_63362316_G_C|0.0941|0.946;chr5_63479008_C_G|0.141|0.961;chr5_63657894_G_A|0.731|1	1.3	NA	NA	NA
chr12_115632318_T_C	false	12	7.110000000000001e-8	7.15	-0.0768	0.7144835770006726	0.0981	RP11-1028N23.4	NA	chr12_115632318_T_C|0.00923|1	1.06	NA	NA	NA
chr10_105786858_T_G	false	10	8.67e-8	7.06	-0.887	0.36689341	0.000657	NA	NA	chr10_105786858_T_G|0.709|1	0.9790000000000001	NA	NA	NA
chr20_59205082_G_A	false	20	9.039999999999999e-8	7.04	-0.0984	6.1579401362831865	0.0571	ZNF831	NA	chr20_59205082_G_A|0.000634|1	1.15	NA	systolic blood pressure|0.19;platelet count|0.19;mean platelet volume|0.177;hematocrit|0.125;hair colour measurement|0.115	NA
chr7_860073_A_C	false	7	1.0199999999999999e-7	6.99	0.0453	1.1377918511837652	0.5539999999999999	SUN1	NA	chr7_860073_A_C|0.541|1	0.922	NA	atrial fibrillation|0.649;PR interval|0.553;self reported educational attainment|0.371;red blood cell distribution width|0.279	NA
chr1_26958422_C_T	true	1	1.42e-7	6.85	0.121	1.5274569952755908	0.0348	KDF1	NA	chr1_26661155_A_G|0.00983|0.841;chr1_26668271_A_G|0.00282|0.3;chr1_26673744_A_G|0.00282|0.3;chr1_26684509_T_TC|0.00605|0.196;chr1_26690834_C_T|0.0052|0.435;chr1_26691718_A_T|0.00365|0.433;chr1_26693253_T_C|0.00425|0.431;chr1_26693602_AT_A|0.00448|0.433;chr1_26693642_C_T|0.00448|0.433;chr1_26694100_T_C|0.00448|0.433;chr1_26694624_G_T|0.00448|0.433;chr1_26695422_G_C|0.0258|0.923;chr1_26699449_C_G|0.00447|0.433;chr1_26700496_C_G|0.00447|0.433;chr1_26701425_G_T|0.00447|0.433;chr1_26701730_A_G|0.00447|0.433;chr1_26701808_A_G|0.00447|0.433;chr1_26707898_A_C|0.00447|0.433;chr1_26707937_A_G|0.00447|0.433;chr1_26708697_C_CT|0.0048|0.436;chr1_26708818_C_G|0.00447|0.433;chr1_26709981_G_A|0.00398|0.433;chr1_26710207_G_A|0.00378|0.433;chr1_26710347_TCGCTTGAACCTGGGAGGCAGAGGTTGCAGTGAGCCGAGATCA_T|0.00304|0.439;chr1_26710663_T_G|0.00447|0.433;chr1_26711498_A_G|0.00447|0.433;chr1_26711725_T_C|0.00447|0.433;chr1_26712737_C_T|0.00447|0.433;chr1_26714018_T_C|0.00447|0.433;chr1_26714727_A_T|0.00447|0.433;chr1_26719679_G_C|0.00447|0.433;chr1_26721033_G_A|0.00447|0.433;chr1_26721402_A_G|0.00447|0.433;chr1_26721463_A_G|0.00447|0.433;chr1_26722492_G_C|0.00447|0.433;chr1_26724087_A_T|0.00447|0.433;chr1_26724732_A_G|0.00447|0.433;chr1_26724828_G_A|0.00447|0.433;chr1_26725756_G_A|0.00447|0.433;chr1_26726121_T_C|0.00415|0.434;chr1_26727525_A_G|0.00447|0.433;chr1_26728289_G_C|0.00447|0.433;chr1_26730152_G_A|0.00249|0.436;chr1_26731130_A_C|0.00447|0.433;chr1_26736052_T_C|0.00447|0.433;chr1_26738708_G_A|0.00447|0.433;chr1_26741747_C_T|0.00447|0.433;chr1_26742480_A_G|0.00447|0.433;chr1_26742678_T_C|0.00447|0.433;chr1_26744038_T_C|0.00447|0.433;chr1_26746016_A_AC|0.00448|0.433;chr1_26746275_A_T|0.00448|0.433;chr1_26747433_C_T|0.00448|0.433;chr1_26747851_AAAAC_A|0.00448|0.433;chr1_26749168_AAATAAT_AAATAATAAT|0.00547|0.435;chr1_26749193_G_A|0.00447|0.433;chr1_26750763_T_A|0.00447|0.433;chr1_26751875_G_A|0.00448|0.433;chr1_26752685_C_T|0.00448|0.433;chr1_26753403_A_G|0.00448|0.433;chr1_26753440_T_C|0.00446|0.433;chr1_26756480_A_C|0.00394|0.436;chr1_26759071_T_C|0.00448|0.433;chr1_26759736_G_C|0.00448|0.433;chr1_26759758_C_T|0.00448|0.433;chr1_26761777_G_A|0.00448|0.433;chr1_26762955_G_C|0.00448|0.433;chr1_26765831_T_C|0.00448|0.433;chr1_26767220_G_C|0.00446|0.433;chr1_26767665_A_G|0.00721|0.197;chr1_26768641_A_G|0.00446|0.433;chr1_26771828_G_A|0.00447|0.433;chr1_26776337_T_C|0.00446|0.433;chr1_26778568_C_T|0.00447|0.433;chr1_26780772_T_TC|0.00341|0.425;chr1_26781648_A_T|0.00447|0.433;chr1_26781754_T_C|0.00447|0.433;chr1_26787521_T_C|0.00447|0.433;chr1_26787956_G_A|0.00447|0.433;chr1_26791680_T_C|0.00447|0.433;chr1_26795430_C_A|0.00447|0.433;chr1_26798054_A_G|0.00446|0.433;chr1_26804737_C_T|0.00446|0.433;chr1_26807930_T_C|0.00445|0.433;chr1_26811902_C_T|0.0038|0.433;chr1_26812738_A_G|0.00752|0.199;chr1_26813370_G_A|0.00446|0.433;chr1_26813658_G_A|0.00446|0.433;chr1_26815377_A_G|0.00445|0.433;chr1_26816063_T_C|0.00754|0.199;chr1_26820282_C_CAAAAAAA|0.00754|0.199;chr1_26820453_G_T|0.00752|0.199;chr1_26821780_T_C|0.00752|0.199;chr1_26827979_G_A|0.00688|0.199;chr1_26828675_C_T|0.00697|0.199;chr1_26831300_G_GA|0.00842|0.199;chr1_26831853_C_T|0.00422|0.433;chr1_26832353_G_T|0.0107|0.198;chr1_26841697_G_C|0.0126|0.199;chr1_26842709_T_G|0.0126|0.199;chr1_26842993_T_C|0.0125|0.199;chr1_26844092_T_C|0.0136|0.197;chr1_26846958_T_C|0.015|0.203;chr1_26848285_C_T|0.00279|0.442;chr1_26848475_A_G|0.00279|0.442;chr1_26849628_A_G|0.00282|0.442;chr1_26849940_T_A|0.0128|0.199;chr1_26851416_C_G|0.0129|0.199;chr1_26851434_T_A|0.00284|0.442;chr1_26853597_A_C|0.0298|0.937;chr1_26854576_C_T|0.00286|0.442;chr1_26855770_A_G|0.0128|0.199;chr1_26858624_T_A|0.0125|0.199;chr1_26859658_A_G|0.00267|0.441;chr1_26859994_T_C|0.0125|0.199;chr1_26860240_T_C|0.0125|0.199;chr1_26861384_CT_C|0.00316|0.438;chr1_26861390_T_G|0.00299|0.438;chr1_26861566_G_A|0.0027|0.442;chr1_26864920_A_T|0.00684|0.199;chr1_26868145_T_TTG|0.00707|0.199;chr1_26869181_G_T|0.00962|0.196;chr1_26870872_C_T|0.00266|0.443;chr1_26871242_T_A|0.00729|0.199;chr1_26872446_C_G|0.00733|0.199;chr1_26873665_T_C|0.00744|0.199;chr1_26877237_A_T|0.00281|0.443;chr1_26877692_T_C|0.00764|0.199;chr1_26880827_A_ATATAC|0.00818|0.199;chr1_26882948_A_G|0.00836|0.199;chr1_26883314_G_GC|0.00812|0.197;chr1_26885748_T_C|0.00853|0.199;chr1_26886550_T_C|0.00859|0.199;chr1_26886588_A_G|0.00856|0.199;chr1_26886871_T_C|0.0034|0.443;chr1_26887623_A_G|0.00864|0.199;chr1_26887754_A_G|0.00869|0.199;chr1_26888588_T_C|0.00439|0.447;chr1_26894030_T_G|0.00423|0.234;chr1_26895118_A_G|0.00152|0.431;chr1_26899598_G_A|0.00143|0.431;chr1_26902878_G_A|0.00139|0.424;chr1_26903485_T_C|0.00144|0.431;chr1_26903542_G_A|0.00144|0.431;chr1_26906354_A_G|0.00455|0.234;chr1_26906721_C_G|0.00145|0.431;chr1_26908191_G_A|0.00467|0.224;chr1_26909721_T_C|0.00447|0.234;chr1_26910266_C_G|0.00455|0.234;chr1_26914534_A_G|0.00455|0.234;chr1_26916030_T_G|0.00455|0.234;chr1_26916604_T_C|0.00455|0.234;chr1_26917027_A_G|0.00455|0.234;chr1_26917784_G_C|0.00136|0.431;chr1_26918872_A_G|0.00455|0.234;chr1_26918922_C_T|0.00136|0.431;chr1_26919293_C_T|0.00136|0.431;chr1_26921075_T_C|0.00136|0.431;chr1_26921331_G_A|0.00455|0.234;chr1_26921792_C_G|0.00136|0.431;chr1_26922154_A_G|0.00455|0.234;chr1_26934292_C_T|0.00655|0.463;chr1_26935894_G_C|0.00192|0.438;chr1_26935895_AGGTGGT_A|0.00154|0.432;chr1_26958422_C_T|0.0419|1;chr1_26965971_G_A|0.00149|0.431;chr1_26966187_T_A|0.00138|0.431;chr1_26966865_T_G|0.00139|0.431;chr1_26968531_T_C|0.00139|0.432;chr1_26972073_C_A|0.00143|0.432	2.17	C-reactive protein measurement|0.937;systolic blood pressure|0.937;body height|0.923;alcohol consumption measurement|0.923;low density lipoprotein cholesterol measurement|0.923;alcohol drinking|0.923;high density lipoprotein cholesterol measurement|0.923;metabolic syndrome|0.923;triglyceride measurement|0.923;apolipoprotein B measurement|0.923;Agents acting on the renin-angiotensin system use measurement|0.841;apolipoprotein A 1 measurement|0.433;xaa‐pro aminopeptidase 2 measurement|0.433;serum alanine aminotransferase measurement|0.433;response to combination chemotherapy|0.433;acute lymphoblastic leukemia|0.433;hair colour measurement|0.433;eosinophil count|0.431;blood pressure|0.199;cardiovascular disease|0.199;chronic obstructive pulmonary disease|0.199;mathematical ability|0.199	C-reactive protein measurement|0.937;systolic blood pressure|0.937;high density lipoprotein cholesterol measurement|0.923;alcohol consumption measurement|0.923;low density lipoprotein cholesterol measurement|0.923;alcohol drinking|0.923;metabolic syndrome|0.923;body height|0.923;apolipoprotein B measurement|0.923;triglyceride measurement|0.923;Agents acting on the renin-angiotensin system use measurement|0.841;apolipoprotein A 1 measurement|0.433;acute lymphoblastic leukemia|0.433;response to combination chemotherapy|0.433;serum alanine aminotransferase measurement|0.433;xaa‐pro aminopeptidase 2 measurement|0.433;hair colour measurement|0.433;eosinophil count|0.431;blood pressure|0.199;chronic obstructive pulmonary disease|0.199;cardiovascular disease|0.199;mathematical ability|0.199	NA
chr4_155524028_T_C	true	4	2e-7	6.7	-0.057999999999999996	0.9187552719691444	0.8270000000000001	NA	NA	chr4_155511216_A_C|0.0772|1;chr4_155512368_G_T|0.0753|1;chr4_155513012_A_C|0.0774|1;chr4_155513765_A_G|0.0702|0.998;chr4_155514565_G_A|0.0753|1;chr4_155515355_G_A|0.0856|0.999;chr4_155517288_C_T|0.0753|1;chr4_155520994_T_A|0.0753|1;chr4_155524028_T_C|0.0865|1;chr4_155526317_A_G|0.0757|1;chr4_155526459_A_G|0.0757|1;chr4_155553642_A_T|0.0161|0.664;chr4_155582247_G_C|0.0199|0.654;chr4_155590150_C_T|0.018|0.654;chr4_155593727_G_A|0.0323|0.631;chr4_155594843_A_G|0.0282|0.633	1.64	NA	cardiovascular disease|0.296;systolic blood pressure|0.296;Diuretic use measurement|0.296;diastolic blood pressure|0.28;coronary artery disease|0.272;Calcium channel blocker use measurement|0.272;Agents acting on the renin-angiotensin system use measurement|0.102	NA
chr17_48880625_A_G	true	17	4.46e-7	6.35	0.0427	1.0181090562944068	0.52	SUMO2P17	chr17_48934535_C_T|missense_variant|0.0485	chr17_48758804_G_A|0.00726|0.688;chr17_48880334_G_C|0.0232|0.0455;chr17_48880625_A_G|0.0244|0.0454;chr17_48881846_G_A|0.00444|0.164;chr17_48889588_T_C|0.0152|0.0489;chr17_48889675_T_A|0.014|0.0489;chr17_48889676_T_A|0.014|0.0489;chr17_48889699_C_T|0.0167|0.0489;chr17_48889762_G_A|0.0167|0.0489;chr17_48890646_G_C|0.016|0.0489;chr17_48892007_G_A|0.0148|0.0489;chr17_48892013_GCCA_G|0.0148|0.0489;chr17_48892303_A_T|0.0147|0.0489;chr17_48892721_G_GA|0.00871|0.0486;chr17_48893778_G_A|0.00656|0.0484;chr17_48895117_ATCTC_A|0.00651|0.0484;chr17_48895503_C_T|0.00656|0.0484;chr17_48897372_T_C|0.00667|0.0484;chr17_48897788_AG_A|0.00656|0.0484;chr17_48898008_G_A|0.00656|0.0484;chr17_48899419_C_T|0.00508|0.0484;chr17_48899763_G_A|0.00541|0.0484;chr17_48900100_T_G|0.00651|0.0484;chr17_48900554_A_G|0.00656|0.0484;chr17_48900921_A_G|0.00667|0.0484;chr17_48902956_C_T|0.00646|0.0484;chr17_48904965_T_A|0.00646|0.0484;chr17_48905387_G_C|0.00646|0.0484;chr17_48905809_G_C|0.00642|0.0484;chr17_48906029_G_A|0.00642|0.0484;chr17_48906680_T_A|0.00632|0.0484;chr17_48907063_C_T|0.00642|0.0484;chr17_48907470_A_C|0.00714|0.0484;chr17_48908231_A_C|0.00642|0.0484;chr17_48909317_A_G|0.00689|0.0484;chr17_48911167_A_G|0.00666|0.0485;chr17_48911235_C_T|0.00557|0.0485;chr17_48911992_A_G|0.00649|0.0485;chr17_48913439_C_A|0.00663|0.0485;chr17_48914169_T_C|0.00663|0.0485;chr17_48914194_A_G|0.00652|0.0485;chr17_48914390_G_A|0.00663|0.0485;chr17_48916008_G_A|0.00663|0.0485;chr17_48916305_T_G|0.00633|0.0485;chr17_48917034_C_T|0.00663|0.0485;chr17_48917484_G_C|0.00663|0.0485;chr17_48917608_G_A|0.00663|0.0485;chr17_48917942_T_A|0.0077|0.164;chr17_48918373_A_G|0.00663|0.0485;chr17_48919070_C_T|0.00716|0.0485;chr17_48919072_G_C|0.00716|0.0485;chr17_48919221_T_A|0.00663|0.0485;chr17_48920636_T_C|0.00653|0.0485;chr17_48920756_T_C|0.00653|0.0485;chr17_48921540_A_G|0.00663|0.0485;chr17_48922011_C_G|0.00663|0.0485;chr17_48922311_T_C|0.00663|0.0485;chr17_48922575_C_T|0.00653|0.0485;chr17_48922748_C_T|0.00653|0.0485;chr17_48924439_A_G|0.00668|0.0485;chr17_48925027_G_A|0.00663|0.0485;chr17_48925077_G_T|0.00674|0.0486;chr17_48925162_G_A|0.00663|0.0485;chr17_48925181_A_G|0.0021|0.102;chr17_48925859_G_T|0.00792|0.0481;chr17_48927831_A_G|0.00463|0.0486;chr17_48928147_T_G|0.00615|0.0486;chr17_48928226_C_T|0.00905|0.048;chr17_48928704_T_TTGA|0.00411|0.164;chr17_48929131_T_C|0.00649|0.0485;chr17_48929588_T_C|0.00663|0.0485;chr17_48930845_A_G|0.00653|0.0485;chr17_48931395_A_T|0.00663|0.0485;chr17_48932473_G_A|0.00663|0.0485;chr17_48932672_G_T|0.00663|0.0485;chr17_48933433_CAG_C|0.00663|0.0485;chr17_48934258_C_G|0.00653|0.0485;chr17_48934535_C_T|0.00663|0.0485;chr17_48935142_A_G|0.00907|0.0484;chr17_48936355_AT_A|0.00658|0.0485;chr17_48936765_T_C|0.00663|0.0485;chr17_48937467_A_AT|0.00653|0.0485;chr17_48939520_C_T|0.00665|0.0467;chr17_48939814_T_C|0.00663|0.0485;chr17_48940115_T_C|0.00604|0.0486;chr17_48940517_G_A|0.00622|0.0485;chr17_48940663_A_G|0.00658|0.0485;chr17_48941687_A_T|0.00741|0.0485;chr17_48942037_A_C|0.00668|0.0485;chr17_48942235_T_C|0.00649|0.0485;chr17_48942310_C_A|0.00663|0.0485;chr17_48942537_C_T|0.00668|0.0485;chr17_48944056_A_C|0.00698|0.0485;chr17_48944066_C_G|0.00653|0.0485;chr17_48944908_C_T|0.00663|0.0485;chr17_48945393_C_G|0.00663|0.0485;chr17_48945499_A_G|0.00663|0.0485;chr17_48948714_G_A|0.00266|0.0441;chr17_48948823_A_T|0.00266|0.0441;chr17_48949069_C_T|0.00266|0.0441;chr17_48949474_G_C|0.00266|0.0441;chr17_48950972_G_A|0.00176|0.044;chr17_48951627_T_C|0.00181|0.044;chr17_48951918_G_C|0.00184|0.0439;chr17_48952542_C_T|0.00184|0.0439;chr17_48954379_A_C|0.00184|0.0439;chr17_48955049_G_A|0.0018|0.044;chr17_48955258_G_C|0.00172|0.044;chr17_48957057_A_G|0.0016|0.044;chr17_48957058_C_T|0.0016|0.044;chr17_48958931_C_T|0.00249|0.0444;chr17_48961109_A_G|0.0106|0.0493;chr17_48961892_T_C|0.00863|0.0493;chr17_48962971_G_A|0.0091|0.0493;chr17_48963329_T_A|0.00985|0.0493;chr17_48963400_T_C|0.00985|0.0493;chr17_48963529_G_T|0.00985|0.0493;chr17_48964755_G_A|0.00975|0.0493;chr17_48965389_A_G|0.00881|0.0493;chr17_48967959_T_C|0.0131|0.0493;chr17_48967960_G_A|0.0131|0.0493;chr17_48968000_C_T|0.0131|0.0493;chr17_48968914_A_G|0.0132|0.0494;chr17_48969752_A_G|0.0119|0.0496;chr17_48970506_G_A|0.0113|0.0507;chr17_48991624_T_G|0.00501|0.174;chr17_49034037_C_T|0.00159|0.108;chr17_49034385_T_C|0.00159|0.108;chr17_49040413_C_T|0.00161|0.108;chr17_49041161_A_G|0.00161|0.108;chr17_49043105_A_G|0.0016|0.108;chr17_49045163_T_C|0.00161|0.108;chr17_49062230_T_C|0.00596|1;chr17_49068486_T_C|0.00168|0.106	2.23	C-reactive protein measurement|0.174;systolic blood pressure|0.0493;type II diabetes mellitus|0.0485;coronary heart disease|0.0485;body height|0.0484;triglyceride measurement|0.0454;high density lipoprotein cholesterol measurement|0.0454;household income|0.0439	self reported educational attainment|0.837;type II diabetes mellitus|0.723;BMI-adjusted waist circumference|0.545;smoking behaviour measurement|0.382;Type 2 Diabetes Mellitus|0.259;systolic blood pressure|0.259;cognitive function measurement|0.252;body mass index|0.252;intelligence|0.252;insomnia measurement|0.234;cardiovascular disease|0.234;alcohol use disorder measurement|0.205;longitudinal alcohol consumption measurement|0.205;neutrophil count|0.195;lean body mass|0.186;C-reactive protein measurement|0.174;HMG CoA reductase inhibitor use measurement|0.155;Agents acting on the renin-angiotensin system use measurement|0.155;Calcium channel blocker use measurement|0.155;odontogenesis|0.145;tooth eruption|0.145;alcohol consumption measurement|0.129;visceral adipose tissue measurement|0.108;coronary heart disease|0.0485;body height|0.0484;triglyceride measurement|0.0454;high density lipoprotein cholesterol measurement|0.0454;household income|0.0439	NA
chr17_49417235_CAAAT_CAAATAAAT	true	17	4.870000000000001e-7	6.31	0.0464	NA	0.32899999999999996	PHB	NA	chr17_49405591_G_A|0.0119|0.74;chr17_49405765_CACAAACAA_CACAA|0.032|0.686;chr17_49406866_G_C|0.018|0.827;chr17_49411461_G_T|0.0179|0.828;chr17_49412740_G_A|0.0572|0.878;chr17_49417235_CAAAT_CAAATAAAT|0.295|1;chr17_49417420_CA_C|0.0801|0.884;chr17_49419998_G_A|0.137|0.881;chr17_49421440_GTC_G|0.0794|0.883;chr17_49429657_G_T|0.0421|0.738;chr17_49432101_A_C|0.026|0.743;chr17_49432124_G_C|0.0664|0.882;chr17_49433211_G_C|0.017|0.689;chr17_49433222_T_C|0.00489|0.823;chr17_49433834_A_G|0.0427|0.717;chr17_49436009_C_T|0.00631|0.628;chr17_49436158_C_T|0.00625|0.628;chr17_49436512_C_T|0.00609|0.627;chr17_49436765_C_A|0.00662|0.627	2.77	coronary artery disease|0.878;hematocrit|0.828;hemoglobin measurement|0.828;leukocyte count|0.828;systolic blood pressure|0.828;autism spectrum disorder|0.74;behavior or behavioral disorder measurement|0.74	coronary artery disease|0.878;hemoglobin measurement|0.828;leukocyte count|0.828;hematocrit|0.828;systolic blood pressure|0.828;autism spectrum disorder|0.74;behavior or behavioral disorder measurement|0.74;FEV/FEC ratio|0.416;appendicular lean mass|0.416;Alzheimer’s disease (proxy)|0.175;triglyceride measurement|0.171;Eczema|0.171;intraocular pressure measurement|0.169;alcohol consumption measurement|0.147;mean arterial pressure|0.147;diastolic blood pressure|0.147;alcohol drinking|0.147;asthma|0.122;Agents acting on the renin-angiotensin system use measurement|0.122;monocyte count|0.122;self rated health|0.122;atopic asthma|0.109;body height|0.109;allergy|0.109;eosinophil count|0.109;respiratory system disease|0.109;atopic eczema|0.109;allergic rhinitis|0.109;Inhalant adrenergic use measurement|0.109;eosinophil percentage of granulocytes|0.109;childhood onset asthma|0.109;smoking status measurement|0.105;cigarettes per day measurement|0.105;cardiovascular disease|0.105	NA
chr23_53192421_C_T	false	23	5.529999999999999e-7	6.26	-0.13699999999999998	19.908065	0.0164	KDM5C	NA	chr23_53192421_C_T|0.000531|1	1.02	NA	NA	NA
chr10_95059456_G_T	true	10	0.506	0.29600000000000004	0.0063	0.9523311533661741	0.275	CYP2C8	NA	chr10_94992391_A_C|0.012|0.315;chr10_95028804_A_G|0.0251|0.999;chr10_95029950_C_G|0.0273|0.999;chr10_95032571_G_A|0.0273|0.999;chr10_95034338_G_GA|0.0325|0.999;chr10_95041116_T_C|0.0284|0.999;chr10_95042172_A_G|0.0284|0.999;chr10_95042367_A_C|0.0284|0.999;chr10_95049129_G_A|0.0315|0.998;chr10_95051215_C_T|0.0284|0.999;chr10_95051708_T_C|0.0287|0.999;chr10_95051799_T_G|0.0262|0.996;chr10_95052473_C_T|0.0281|0.998;chr10_95054175_T_C|0.0292|1;chr10_95054718_T_C|0.0299|1;chr10_95055357_T_G|0.0299|1;chr10_95057319_G_T|0.0304|1;chr10_95059076_C_T|0.0304|1;chr10_95059420_T_C|0.0321|1;chr10_95059456_G_T|0.036|1;chr10_95059944_A_G|0.0304|1;chr10_95060359_G_A|0.0296|1;chr10_95060813_G_A|0.0304|1;chr10_95061291_A_C|0.0304|1;chr10_95062563_C_G|0.0304|1;chr10_95063364_C_G|0.0304|1;chr10_95064482_A_G|0.0304|1;chr10_95064649_C_T|0.0289|0.999;chr10_95065218_C_T|0.0304|1;chr10_95066271_C_T|0.0351|1;chr10_95068566_T_C|0.0167|0.993;chr10_95081773_A_C|0.024|0.98;chr10_95081775_A_T|0.0198|0.927;chr10_95086085_TA_T|0.0195|0.993	4.86	blood metabolite measurement|0.999;urinary metabolite measurement|0.993;chronic kidney disease|0.993	blood metabolite measurement|0.999;urinary metabolite measurement|0.993;chronic kidney disease|0.993;hemoglobin measurement|0.119	NA